document,document_id,arm,arm_id,control,Biochemical verification,CBT,Motivational Interviewing,brief advise,1.1.Goal setting,1.2 Problem solving,1.4 Action planning,2.2 Feedback on behaviour,2.3 Self-monitoring of behavior,3.1 Social support,4.1 Instruction on how to perform the behavior,4.5. Advise to change behavior,5.1 Information about health consequences,5.3 Information about social and environmental consequences,11.1 Pharmacological support,11.2 Reduce negative emotions,Group-based,Face to face,phone,Website / Computer Program / App,Patch,Somatic,gum,e_cigarette,inhaler,lozenge,nasal_spray,placebo,nrt,Pill,bupropion,varenicline,Printed material,Digital content type,text messaging,Health Professional,doctor,nurse,pychologist,aggregate patient role,Mean age,Proportion identifying as female gender,Mean number of times tobacco used,Country of intervention,healthcare facility,Pharmaceutical company funding,Pharmaceutical company competing interest,Individual-level analysed,Combined follow up,Abstinence type,Abstinence: Continuous ,Abstinence: Point Prevalence ,Manually added follow-up duration value,Manually added follow-up duration units,NEW Outcome value
2014 StopAdvisor outcome paper.pdf,252978,Control,92,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.8,62,18.5,UK,0,0,1,2292,26.10,C,1,0,6,months,10
2014 StopAdvisor outcome paper.pdf,252978,StopAdvisor,87,0,1,0,0,0,1,0,1,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.5,63,18.7,UK,0,0,1,2321,26.10,C,1,0,6,months,10
2015 EARS outcome paper 1.pdf,252982,Exercise Assisted Reduction to Stopping Smoking (EARRS),19,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,-,-,United Kingdom,0,0,0,-,4.00,C,1,0,4,weeks,14.3
2015 EARS outcome paper 1.pdf,252982,Usual Care,20,1,1,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,United Kingdom,0,0,0,-,4.00,C,1,0,4,weeks,4
2015 LEAP trial outcome paper.pdf,252984,Supervised Exercise,21,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.2,-,-,multinational,0,0,1,392,-,C,1,0,na,,8
2015 LEAP trial outcome paper.pdf,252984,Control,22,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.8,-,-,multinational,0,0,1,393,-,C,1,0,na,,6
2016 Babex trial main outcome paper.pdf,252980,Single face-to-face session of quit advice plus a single training session on yogic breathing exercises (BAY-BE),15,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,45.2,22.6,-,India,0,0,1,611,26.10,C,1,0,6,months,2.6
2016 Babex trial main outcome paper.pdf,252980,Single face-to-face session of quit advice (VBA),16,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,47.4,17.9,-,India,0,0,1,602,26.10,C,1,0,6,months,0.5
2016 EAGLES outcome paper.pdf,252976,Non-psychiatric & Bupropion,27,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,46,49,20.6,multinational,0,1,1,1001,12.00,C,1,0,12,weeks,18.8
2016 EAGLES outcome paper.pdf,252976,Non Psychiatric & Nicotine Patch,28,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,46.1,51,20.8,multinational,0,1,1,1013,12.00,C,1,0,12,weeks,18.5
2016 EAGLES outcome paper.pdf,252976,Non-psychiatric & Placebo,29,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,45.9,51,20.5,multinational,0,1,1,1009,12.00,C,1,0,12,weeks,10.5
2016 EAGLES outcome paper.pdf,252976,Psychiatric & Bupropion,24,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,46.7,62,20.5,multinational,0,1,1,1033,12.00,C,1,0,12,weeks,13.7
2016 EAGLES outcome paper.pdf,252976,Psychiatric & Nicotine Patch,25,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,47.6,62,20.8,multinational,0,1,1,1025,12.00,C,1,0,12,weeks,13
2016 EAGLES outcome paper.pdf,252976,Non-psychiatric & varencline,30,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,45.8,48,20.8,multinational,0,1,1,1005,12.00,C,1,0,12,weeks,25.5
2016 EAGLES outcome paper.pdf,252976,Psychiatric & Varenicline,23,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,47.2,62,20.6,multinational,0,1,1,1032,12.00,C,1,0,12,weeks,18.3
2016 EAGLES outcome paper.pdf,252976,Psychiatric & Placebo,26,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,46.9,62,20.7,multinational,0,1,1,1026,12.00,C,1,0,12,weeks,8.3
Abdullah 2005.pdf,296253,Intervention group,17,0,0,0,0,0,0,1,0,0,0,1,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,-,15.8,14.5,China,0,0,0,444,26.10,PP,0,1,,,15.3
Abdullah 2005.pdf,296253,Control group,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,16.1,14.5,China,0,0,0,459,26.10,PP,0,1,,,7.4
Abrantes 2014.pdf,263048,Aerobic Exercise - AE,3,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,47.1,63.3,20.3,-,0,0,0,30,52.20,PP,0,1,12,months,26.7
Abrantes 2014.pdf,263048,Health education control - HEC,4,1,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,47.5,67.7,19.4,-,0,0,0,31,52.20,PP,0,1,12,months,12.9
Abroms 2008.pdf,263049,X-Pack,6,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,19.8,47.9,9.9,-,0,0,0,48,26.10,PP,0,1,6,months,10.2
Abroms 2008.pdf,263049,Clearing the Air (CTA),7,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19.8,42.9,8,-,0,0,0,35,26.10,PP,0,1,6,months,5.7
Abroms 2014.pdf,263050,Control,118,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.5,62.8,16.86,U.S.,0,0,0,241,26.10,PP,0,1,6,months,5
Abroms 2014.pdf,263050,Text2Quit,117,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,35.9,68.7,17.68,U.S.,0,0,0,262,26.10,PP,0,1,6,months,11.1
Abroms 2017.pdf,436345,Intervention,2589,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,26.68,-,7.48,U.S.,0,0,1,250,13.05,PP,0,1,,,15.6
Abroms 2017.pdf,436345,Control,2590,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,25.95,-,7.25,U.S.,0,0,1,247,13.05,PP,0,1,,,10.93
Ahluwalia 2006 (c) primary paper .pdf,263051,Nicotine Gum + Motivational Interviewing (MI),119,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,45.2,66.1,7.8,-,0,1,1,189,26.00,PP,0,1,26,weeks,10.1
Ahluwalia 2006 (c) primary paper .pdf,263051,Placebo Gum + HE,122,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,45.2,68.1,7.3,-,0,1,1,188,26.00,PP,0,1,26,weeks,15.4
Ahluwalia 2006 (c) primary paper .pdf,263051,Placebo Gum + MI,121,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,46.5,65.1,7.5,-,0,1,1,189,26.00,PP,0,1,26,weeks,6.9
Ahluwalia 2006 (c) primary paper .pdf,263051,Nicotine Gum + Health Education (HE),120,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,43.5,68.3,7.5,-,0,1,1,189,26.00,PP,0,1,26,weeks,18
Aimer 2017.pdf,423105,Control,2058,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,57,47,16.4,New Zealand,0,0,1,19,26.10,C,1,0,,,21
Aimer 2017.pdf,423105,Intervention,2057,0,0,0,0,1,1,1,0,0,0,0,0,1,1,0,1,0,0,1,1,1,0,1,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,56,63,16.6,New Zealand,0,0,1,19,26.10,C,1,0,,,26
Alessi 2017.pdf,436347,mHealth monitoring,2614,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,45.5,60,20,-,0,0,0,45,24.00,PP,0,1,,,16.3
Alessi 2017.pdf,436347,mHealth reinforcement,2613,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,44.4,55.6,17.6,-,0,0,0,45,24.00,PP,0,1,,,21.1
Ames 2007.pdf,263055,Brief office (control),126,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20.8,56,18.2,-,0,0,0,99,52.00,PP,0,1,52,weeks,11
Ames 2007.pdf,263055,Expressive writing plus brief office,125,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20.9,57,18.1,-,0,0,0,97,52.00,PP,0,1,52,weeks,11
Ames 2014.pdf,263056,Standard intervention,128,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24.4,43,13.4,-,0,0,0,47,26.10,PP,0,1,6,months,9
Ames 2014.pdf,263056,Integrated intervention,127,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24.1,46,13.3,-,0,0,0,48,26.10,PP,0,1,6,months,21
An 2006.pdf,296254,Telephone care,452,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,57.2,8.40000000000001,26.2,-,1,0,0,407,52.20,C,1,0,,,13
An 2006.pdf,296254,Standard care,453,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,1,57.1,9.5,26.7,-,1,0,0,414,52.20,C,1,0,,,4.1
Anderson 2018.pdf,437478,NP,2275,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,68,17.4,United States,0,0,0,1405,30.45,C,1,0,,,10.3
Anderson 2018.pdf,437478,NP+FI,2274,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46.5,67.7,17.1,United States,0,0,0,1407,30.45,C,1,0,,,13.2
Anderson 2018.pdf,437478,UC,2276,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.1,67.2,17.7,United States,0,0,0,1004,30.45,C,1,0,,,9
Auguston 2017.pdf,436348,Low-frequency text contact (LFTC),2622,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,-,-,-,China,0,0,0,4000,26.10,PP,0,1,,,27.7
Auguston 2017.pdf,436348,High-frequency text contact (HFTC),2621,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,-,-,-,China,0,0,0,4000,26.10,PP,0,1,,,27.7
Aung 2019.pdf,437433,Control,2217,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,-,28.75,-,Thailand,0,0,0,159,52.20,PP,0,1,,,11.32
Aung 2019.pdf,437433,Intervention,2216,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,-,28.93,-,Thailand,0,0,0,160,52.20,PP,0,1,,,25.62
Aveyard 2003.pdf,296255,Nurse,454,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,42,57.1,-,-,1,0,0,413,12.00,pp,0,1,,,3.4
Aveyard 2003.pdf,296255,Control,457,1,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,53.2,-,-,0,0,0,690,12.00,pp,0,1,,,2.2
Aveyard 2003.pdf,296255,Phone,455,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,57.2,-,-,0,0,0,685,12.00,pp,0,1,,,3.1
Aveyard 2003.pdf,296255,Manual,456,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,55.8,-,-,0,0,0,683,12.00,pp,0,1,,,3.4
Aveyard 2007.pdf,296332,Basic,412,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,42.9,52.7,-,UK,0,1,1,469,26.00,C,1,0,,,7.7
Aveyard 2007.pdf,296332,Weekly,411,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,44.3,50.2,-,UK,0,1,1,456,26.00,C,1,0,,,6.6
Aytemur 2012.pdf,321085,Control group,683,1,0,0,0,0,0,1,0,0,0,1,1,1,0,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,46.3,53.8,20,-,0,0,0,52,26.10,NCS,0,0,,,38.5
Aytemur 2012.pdf,321085,Psychodrama group,682,0,0,0,0,0,0,1,0,0,0,1,1,1,0,1,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,0,1,0,1,0,0,48,68.8,20,-,0,0,0,61,26.10,NCS,0,0,,,50.8
Baggett 2018.pdf,437480,Control arm,2278,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.1,56,16.2,United States,1,0,1,25,8.00,C,1,0,,,8
Baggett 2018.pdf,437480,Incentive arm,2277,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48.1,48,15.6,United States,1,0,1,25,8.00,C,1,0,,,48
Bailey 2013.pdf,319572,Non-extended treatment,620,0,1,1,0,0,1,1,0,0,0,1,1,0,1,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,97.1,-,0,0,0,70,26.00,PP,0,1,,,7
Bailey 2013.pdf,319572,Extended treatment,619,0,1,1,0,0,1,1,0,0,0,1,1,0,1,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,97.1,-,0,0,0,71,26.00,PP,0,1,,,21
Baker 2006 (c) primary paper.pdf,263058,motivational interviewing/CBT with nicotine replacement therapy,129,0,1,1,1,0,1,1,1,0,0,0,1,0,1,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,37.24,-,-,Australia,0,1,1,108,52.20,C,1,0,12,months,3.4
Baker 2006 (c) primary paper.pdf,263058,Control,130,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.24,-,-,Australia,0,1,1,109,52.20,C,1,0,12,months,0.7
Baker 2015.pdf,423106,Healthy Lifestyles condition,2059,0,1,0,0,0,0,1,0,1,0,1,0,0,1,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,41.6,41,29.9,Australia,0,1,1,122,52.20,PP,0,1,,,6.6
Baker 2015.pdf,423106,Telephone condition,2060,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,41.6,41,27.2,Australia,0,1,1,113,52.20,PP,0,1,,,6.2
Baker 2016.pdf,423132,Varenicline only,1942,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,48,52,17,United States,0,0,1,424,52.00,PP,0,1,,,19.1
Baker 2016.pdf,423132,Nicotine patch only,1943,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,48,52,17,United States,0,0,1,241,52.00,PP,0,1,,,20.8
Baker 2016.pdf,423132,Nicotine patch + nicotine lozenge (C-NRT),1941,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,48,52,17,United States,0,0,1,421,52.00,PP,0,1,,,20.2
Baker_A_ 2018.pdf,437481,Telephone,2280,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42.7,41,27.2,-,0,0,0,235,156.60,PP,0,1,,,8
Baker_A_ 2018.pdf,437481,Healthy Lifestyles,2279,0,1,0,1,0,0,1,0,0,0,1,1,0,1,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,40.6,42,29.9,-,0,0,0,235,156.60,PP,0,1,,,11
Baker_B_2018.pdf,437482,Control,2303,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,26.1,-,1,-,0,0,0,509,26.10,PP,0,1,6,months,9.2
Baker_B_2018.pdf,437482,Incentive,2302,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,26.7,-,1,-,0,0,0,505,26.10,PP,0,1,6,months,14.7
Baldassarri 2018.pdf,437483,Non-nicotine EC,2314,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,0,53.8,65,17,United States,0,0,1,20,24.00,PP,0,1,,,10
Baldassarri 2018.pdf,437483,Nicotine EC,2313,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,0,52.2,40,17,United States,0,0,1,20,24.00,PP,0,1,,,20
Baskerville 2018.pdf,436349,Crush The Crave (CTC),2623,0,0,0,0,0,1,1,0,1,0,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,45.94,-,Canada,0,0,0,820,26.10,C,1,0,,,12.6
Baskerville 2018.pdf,436349,On the Road to Quitting (OnRQ) control,2624,1,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,-,45.94,-,Canada,0,0,0,779,26.10,C,1,0,,,12.1
Battaglia 2016.pdf,423478,MI-based home telehealth program,1963,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,1,1,1,0,1,1,0,0,1,1,1,1,1,0,0,1,0,1,0,0,54.6,16.9,-,-,1,0,0,89,26.10,PP,0,1,,,23.6
Battaglia 2016.pdf,423478,Usual care,1964,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,1,1,1,0,1,1,0,0,1,1,1,1,0,0,0,0,0,0,0,0,56.6,10.5,-,-,1,0,0,86,26.10,PP,0,1,,,23.3
Begh 2015.pdf,423107,Intervention,2061,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46.5,-,21.8,UK,0,0,1,60,26.10,C,1,0,,,16.7
Begh 2015.pdf,423107,Control,2062,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,-,19.8,UK,0,0,1,58,26.10,C,1,0,,,15.5
Berg 2014.pdf,423040,Control,2010,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,21.16,67.8,15.03,US,0,0,0,59,12.00,PP,0,1,12,weeks,16.7
Berg 2014.pdf,423040,Intervention,2009,0,0,0,0,0,0,1,0,1,1,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,21.16,66.7,3.56,US,0,0,0,63,12.00,PP,0,1,12,weeks,18.9
Berman 1995.pdf,296382,Intervention,751,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.7,50.9,-,-,0,0,0,348,52.20,C,1,0,,,6.4
Berman 1995.pdf,296382,Control,752,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.7,50.9,-,-,0,0,0,348,52.20,C,1,0,,,7.3
Bernard 2015.pdf,436350,Exercise and counselling,2591,0,1,0,0,0,1,1,0,0,0,1,1,1,0,0,1,1,1,1,0,0,0,1,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,48.5,48.6,21.9,France,0,0,1,35,52.00,C,1,0,,,20
Bernard 2015.pdf,436350,Control,2592,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,48.4,68.6,21,France,0,0,1,35,52.00,C,1,0,,,11.4
Berndt 2014.pdf,423108,face-to-face counseling + NRT,2063,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,1,1,0,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,56.54,29.3,22.19,Netherlands,0,0,0,155,26.10,C,1,0,,,40.6
Berndt 2014.pdf,423108,control,2065,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,1,56.09,25.3,19.71,Netherlands,0,0,0,235,26.10,C,1,0,,,31.5
Berndt 2014.pdf,423108,telephone counseling + NRT,2064,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,1,0,1,55.31,26.9,21.13,Netherlands,0,0,0,218,26.10,C,1,0,,,42.2
BinDhim 2018.pdf,436351,Intervention,2632,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.9,57,-,multinational,0,0,0,342,26.10,C,1,0,,,10.2
BinDhim 2018.pdf,436351,Control,2633,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.8,52.9,-,multinational,0,0,0,342,26.10,C,1,0,,,4.8
Bize 2010.pdf,266058,Control,132,1,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.5,38,27,Switzerland,0,0,0,-,52.20,C,1,0,1,years,29
Bize 2010.pdf,266058,Physical Activity,131,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.2,44,26.6,Switzerland,0,0,0,-,52.20,C,1,0,1,years,27
Blebil 2014.pdf,263067,Telephone counselling,133,0,1,0,0,0,0,1,0,1,0,1,1,1,1,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,48.22,5,13.08,Malaysia,0,0,0,-,26.10,PP,0,1,6,months,71.7
Blebil 2014.pdf,263067,Control,134,1,1,0,0,0,0,1,0,0,0,1,1,0,1,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,48.3,2.7,14.54,Malaysia,0,0,0,-,26.10,PP,0,1,6,months,48.6
Blyth 2015.pdf,423083,Control,1913,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.9,51.1,20.4,England,0,0,1,702,52.20,C,1,0,,,38.6
Blyth 2015.pdf,423083,Experimental,1912,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.8,54.2,19.9,England,0,0,1,702,52.20,C,1,0,,,36.9
Bock 2014.pdf,263070,Standard Care (SC),136,1,1,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,39.6,68.7,-,-,1,0,0,208,52.20,PP,0,1,12,months,28
Bock 2014.pdf,263070,Motivational Enhancement (ME),135,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,39.6,68.7,-,-,1,0,0,168,52.20,PP,0,1,12,months,29
Bold 2019.pdf,437436,Placebo,2236,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,42.7,29.8,11.6,-,0,0,1,67,52.20,PP,0,1,,,0
Bold 2019.pdf,437436,Varenicline,2235,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,42.7,29.8,11.6,-,0,0,1,64,52.20,PP,0,1,,,6.3
Bonevski 2018.pdf,437566,Intervention,2607,0,1,0,1,1,1,1,0,0,0,1,0,1,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,49,-,Australia,0,0,1,187,26.10,C,1,0,,,1
Bonevski 2018.pdf,437566,Control,2608,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,48,-,Australia,0,0,1,244,26.10,C,1,0,,,1.4
Borland 2003.pdf,296383,Computer-generated tailored advice and callback telephone counselling,761,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,52.8,23.6,Australia,0,0,0,528,52.20,C,1,0,,,6.1
Borland 2003.pdf,296383,Computer-generated tailored advice only,762,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,51.6,22.5,Australia,0,0,0,523,52.20,C,1,0,,,4.6
Borland 2003.pdf,296383,Control group,763,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,56.7,22.5,Australia,0,0,0,527,52.20,C,1,0,,,4
Borland 2004.pdf,296384,Control,765,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32.3,52.9,-,Australia,0,0,0,537,52.20,C,1,0,,,12
Borland 2004.pdf,296384,Tailored advice,764,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32.3,54.5,-,Australia,0,0,0,521,52.20,C,1,0,,,20
Borland J Fam Pract 2008.pdf,296258,In-practice (standard),459,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,40.7,55.3,17.3,-,1,0,0,311,52.20,C,1,0,,,1.6
Borland J Fam Pract 2008.pdf,296258,Referall,458,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,1,40.7,55.3,17.6,-,0,0,0,728,52.20,C,1,0,,,4.4
Borrelli-2005.pdf,263071,Motivational Enhancement (ME),137,0,1,0,1,0,1,0,0,0,0,0,1,0,1,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,56.9,54.3,20.5,USA,0,0,0,76,52.20,PP,0,1,12,months,17.1
Borrelli-2005.pdf,263071,Standard Care (SC),138,1,1,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,57.5,54.3,21.6,USA,0,0,0,96,52.20,PP,0,1,12,months,10.4
Boyle 2007.pdf,296259,No-contact control,461,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,57.7,-,-,0,0,0,824,52.20,PP,0,1,,,19.8
Boyle 2007.pdf,296259,Proactive recruitment into telephone counseling,460,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47,58.5,-,-,0,0,0,824,52.20,PP,0,1,,,21.1
Brendryen_2008_A digital smoking cessation program delivered_10.2196jmir.1005.pdf,263047,Booklet control,98,1,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,50,17.6,Norwegian,0,0,0,146,52.20,PP,0,1,12,months,7
Brendryen_2008_A digital smoking cessation program delivered_10.2196jmir.1005.pdf,263047,Happy Ending,97,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,39.5,50,16.6,Norwegian,0,0,0,144,52.20,PP,0,1,12,months,20
Bricker 2014.pdf,423110,CBT intervention,2069,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,38.6,73,-,United States,0,0,0,62,26.10,PP,0,1,,,22
Bricker 2014.pdf,423110,ACT intervention,2068,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,1,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.6,66,-,United States,0,0,0,59,26.10,PP,0,1,,,31
Bricker 2014.pdf,423251,SmartQuit (ACT) app,2136,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,41.5,53,-,-,0,0,1,80,8.70,PP,0,1,,,13
Bricker 2014.pdf,423251,QuitGuide app,2137,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,41.6,51,-,-,0,0,1,84,8.70,PP,0,1,,,8
British Thoratic Society 1983.pdf,296397,Verbal advice plus booklet and Nicorette chewing gum (VABNG),766,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,49,37,24,Britain,1,1,1,400,52.20,C,1,0,,,39
British Thoratic Society 1983.pdf,296397,Verbal advice plus booklet and placebo gum (VABPG),767,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,49,37,24,Britain,1,1,1,402,52.20,C,1,0,,,46
British Thoratic Society 1983.pdf,296397,Verbal advice plus booklet (VAB),768,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,49,37,24,Britain,1,1,1,377,52.20,C,1,0,,,32
British Thoratic Society 1983.pdf,296397,Verbal advice alone (VA),769,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,49,37,24,Britain,1,1,1,371,52.20,C,1,0,,,33
Brody 2017.pdf,423111,Treatment as usual (TAU),2072,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,1,0,57.5,-,19.6,Chile,0,0,0,13,26.00,PP,0,1,,,8
Brody 2017.pdf,423111,COMB-EXT without HV,2071,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,1,1,1,1,0,0,1,1,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,56.3,-,18.5,Chile,0,0,0,10,26.00,PP,0,1,,,20
Brody 2017.pdf,423111,COMB-EXT with HV,2070,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,1,1,1,1,0,0,1,1,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,56.1,-,18.6,Chile,0,0,0,11,26.00,PP,0,1,,,45
Brooks 2018.pdf,437485,Intervention,2315,0,1,0,1,0,1,1,1,0,0,1,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,75.2,10,United States,0,0,0,121,52.20,PP,0,1,,,14.9
Brooks 2018.pdf,437485,Control,2316,1,1,0,0,0,0,1,1,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,72.1,10,United States,0,0,0,129,52.20,PP,0,1,,,7.8
Brown 1992.pdf,296260,Manual plus telephone contact,462,0,1,0,0,0,1,1,1,0,1,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,45,22.7,-,1,0,0,45,12.00,PP,0,1,,,30.4
Brown 1992.pdf,296260,Manual only,463,0,1,0,0,0,1,1,1,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,45,22.7,-,1,0,0,45,12.00,PP,0,1,,,9
Brown 2001.pdf,280754,Smoking CBT + depression CBT (CBT-D),139,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,45.1,59.8,27.3,-,0,0,0,86,52.20,PP,0,1,12,months,32.5
Brown 2001.pdf,280754,Smoking CBT,140,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,45.1,59.8,27.3,-,0,0,0,93,52.20,PP,0,1,12,months,24.7
Brown 2003.pdf,319573,Motivation interviewing (MI),621,0,1,0,1,0,1,1,1,0,0,1,1,0,1,1,1,1,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,15.4,62.3,14.48,USA,0,0,0,162,52.20,PP,0,1,,,14
Brown 2003.pdf,319573,Brief advice (BA),622,0,1,0,0,1,1,1,0,0,0,1,1,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,15.4,62.3,14.48,USA,0,0,0,162,52.20,PP,0,1,,,9.9
Brown 2007.pdf,263073,Smoking CBT + Depression CBT + Burproprion (CBTD+BUP),141,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.36,46.3,24.06,-,0,0,0,-,52.20,PP,0,1,12,months,17.6
Brown 2007.pdf,263073,Smoking CBT + placebo (ST+PLAC),144,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.16,47.1,25.54,-,0,0,0,-,52.20,PP,0,1,12,months,15.3
Brown 2007.pdf,263073,Smoking CBT + Depression CBT + Placebo (CBTD+PLAC),142,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.4,44.6,25.4,-,0,0,0,-,52.20,PP,0,1,12,months,17.9
Brown 2007.pdf,263073,Smoking CBT + buproprion (ST+BUP),143,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.89,51,24.46,-,0,0,0,-,52.20,PP,0,1,12,months,22.5
Brown 2018.pdf,437486,Standard Treatment (ST),2318,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,47.31,40.7,20.09,-,0,0,0,54,26.00,PP,0,1,,,22.2
Brown 2018.pdf,437486,DT,2317,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,44.97,41.9,20.11,-,0,0,0,62,26.00,PP,0,1,,,17.7
Brown-2013 primary.pdf,263074,Standard Treatment (ST),146,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,48.3,54.5,21,-,0,0,0,22,26.00,PP,0,1,,,9.1
Brown-2013 primary.pdf,263074,Distress Tolerance (DT),145,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,47.19,44.4,22,-,0,0,0,27,26.00,PP,0,1,,,14.8
Buller 2014.pdf,423252,REQ-Mobile,2138,0,0,0,0,0,1,1,1,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,25.5,45,16.8,U.S.,0,0,0,51,12.00,C,1,0,,,16
Buller 2014.pdf,423252,OnQ text messaging,2139,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,24.3,57,17.1,U.S.,0,0,0,51,12.00,C,1,0,,,27
Burling 1989.pdf,296405,Computer,772,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.64,-,-,-,0,0,0,29,13.05,PP,0,1,,,21.43
Burling 1989.pdf,296405,Contest only,773,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.64,-,-,-,0,0,0,29,13.05,PP,0,1,,,11.54
Burns 2016.pdf,423133,4-week arm,2040,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,59.1,-,Brazil,0,1,1,738,30.45,C,1,0,,,5.7
Burns 2016.pdf,423133,8-week arm,2039,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,60.9,-,Brazil,0,1,1,757,30.45,C,1,0,,,5.6
Busch 2017.pdf,423112,Standard Care (SC),2074,1,1,0,0,0,0,1,1,0,0,1,1,1,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,57.1,35.5,16.9,-,0,0,0,31,24.00,PP,0,1,,,42.3
Busch 2017.pdf,423112,Behavioral Activation Treatment for Cardiac Smokers (BAT-CS),2073,0,1,0,0,0,0,1,1,0,0,1,1,1,1,1,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,53.9,17.9,15.8,-,1,0,0,28,24.00,PP,0,1,,,45.8
Bush 2018.pdf,437489,Simultaneous,2350,0,0,0,0,0,1,1,1,0,1,1,1,0,0,0,1,1,0,0,1,1,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,1,1,0,0,0,43.2,65.8,-,United States,0,0,1,839,52.20,PP,0,1,,,24.1
Bush 2018.pdf,437489,Sequential,2349,0,0,0,0,0,1,1,1,0,1,1,1,0,0,0,1,1,0,0,1,1,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,1,1,0,0,0,43.2,65.8,-,United States,0,0,1,849,52.20,PP,0,1,,,26.9
Bush 2018.pdf,437489,Control,2351,1,0,0,0,0,0,1,1,0,0,1,1,0,0,0,1,1,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43.2,65.8,-,United States,0,0,1,840,52.20,PP,0,1,,,28.2
Caldwell 2014.pdf,423134,Active,2041,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.6,52.3,-,New Zealand,0,1,1,716,52.20,C,1,0,,,9.5
Caldwell 2014.pdf,423134,Placebo,2042,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,45.3,55,-,New Zealand,0,1,1,707,52.20,C,1,0,,,8.5
Caldwell 2016.pdf,423135,Placebo inhaler plus patch,2044,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,45,52,19.2,multinational,0,0,0,256,26.10,C,1,0,,,8.59
Caldwell 2016.pdf,423135,Active inhaler plus patch,2043,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.2,50,19,multinational,0,0,0,246,26.10,C,1,0,,,13.41
Campbell 1986.pdf,296406,How to Stop Smoking booklet,774,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,-,-,-,1,0,0,535,4.35,C,1,0,,,3.9
Campbell 1986.pdf,296406,Control,775,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,-,1,0,0,671,4.35,C,1,0,,,2.7
Campos 2018.pdf,437491,Brief Intervention,2359,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,51.1,37.8,21.2,Brazil,0,0,0,45,26.10,PP,0,1,,,20
Campos 2018.pdf,437491,Intensive Intervention,2358,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,51.1,40,20.2,Brazil,0,0,0,45,26.10,PP,0,1,,,53.3
Canga 2000.pdf,296337,Control,416,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,55.8,13.5,19.8,Spain,1,0,0,133,26.10,NCS,0,0,,,2.3
Canga 2000.pdf,296337,Intervention,415,0,1,0,0,0,1,0,0,0,0,0,0,1,1,1,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,54.4,15,19.9,Spain,1,0,0,147,26.10,NCS,0,0,,,17
Caponnetto 2017.pdf,436352,Intervention,2788,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,-,-,Italy,1,0,0,124,24.00,C,1,0,,,12.2
Caponnetto 2017.pdf,436352,Control,2789,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,-,-,Italy,1,0,0,63,24.00,C,1,0,,,1.6
Carlsson 1997.pdf,296338,Intervention,437,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,1,62,-,-,Sweden,1,0,0,32,52.20,PP,0,1,1,year,50
Carlsson 1997.pdf,296338,Usual Care,438,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,1,61,-,-,Sweden,1,0,0,35,52.20,PP,0,1,1,year,29
Carmody 2008.pdf,263076,Hypnosis,150,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,45,42,20,Mexico,0,0,0,137,52.20,PP,0,1,,,14
Carmody 2008.pdf,263076,Behavioural counselling,149,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,35,20,Mexico,0,0,0,128,52.20,PP,0,1,,,20
Catley 2016.pdf,423479,Health education,1966,0,1,0,0,0,1,1,1,0,0,0,1,1,0,1,1,0,0,1,1,0,1,1,0,0,0,1,0,0,1,1,0,1,1,0,0,1,0,0,0,0,46.7,40,16.9,-,0,1,1,102,26.10,PP,0,1,,,7.8
Catley 2016.pdf,423479,Motivational interviewing,1965,0,1,0,1,0,1,0,1,0,0,1,1,1,0,0,1,0,0,1,1,0,1,1,0,0,0,1,0,0,1,1,0,1,1,0,0,1,0,0,0,0,45,46,16.2,-,0,1,1,102,26.10,PP,0,1,,,2.9
Catley 2016.pdf,423479,Brief advice,1967,0,1,0,0,1,1,0,0,0,0,0,1,1,0,0,1,0,0,1,0,0,1,1,0,0,0,1,0,0,1,1,0,1,1,0,0,1,0,0,0,0,45.5,43,18,-,0,1,1,51,26.10,PP,0,1,,,0
Chan 2018.pdf,437492,Control group,2342,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46.45,17.7,15.23,Hong Kong,0,0,0,390,26.10,PP,0,1,,,6.7
Chan 2018.pdf,437492,Intervention group,2341,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.4,14.7,15.15,Hong Kong,0,0,0,441,26.10,PP,0,1,,,9.1
Chan-2012.pdf,263079,Stage-matched smoking cessation counselling,156,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,58,8.4,12,Hong Kong,0,0,0,938,52.20,PP,0,1,,,26.5
Chan-2012.pdf,263079,Control,157,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,58.6,9.5,11.6,Hong Kong,0,0,0,922,52.20,PP,0,1,,,25.5
Chen 2014.pdf,263081,Individual Counselling,158,0,1,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,50.8,-,19,China,0,0,0,94,26.10,C,1,0,,,23.4
Chen 2014.pdf,263081,Smoking cessation advice,159,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,50.3,-,20.6,China,0,0,0,96,26.10,C,1,0,,,10.4
Cheung 2015.pdf,423084,Facebook (Group B),1915,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,37.6,28,15.3,China,0,0,0,40,26.10,PP,0,1,,,25
Cheung 2015.pdf,423084,WhatsApp (Group A),1914,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,40.4,24,14.5,China,0,0,0,42,26.10,PP,0,1,,,26
Cheung 2015.pdf,423084,Control (Group C),1916,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42.7,20,17.1,China,0,0,0,54,26.10,PP,0,1,,,15
Cheung 2017.pdf,423065,early-informed,2011,0,0,0,0,1,0,1,1,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44,12.7,-,Hong Kong,0,0,0,379,26.10,PP,0,1,,,9
Cheung 2017.pdf,423065,control,2013,1,0,0,0,1,0,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.9,16.9,-,Hong Kong,0,0,0,379,26.10,PP,0,1,,,10.6
Cheung 2017.pdf,423065,late-informed,2012,0,0,0,0,1,0,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.1,21.3,-,Hong Kong,0,0,0,385,26.10,PP,0,1,,,8.3
Cheung 2018.pdf,437494,Usual care,2365,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,40,42,-,United States,0,0,0,635,52.20,PP,0,1,,,18.1
Cheung 2018.pdf,437494,Intervention,2364,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,41,34,-,United States,0,0,0,660,52.20,PP,0,1,,,20.8
Cheung 2019.pdf,437438,Brief Advice,2244,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35.4,12,13.9,Hong Kong,0,0,0,50,26.10,PP,0,1,,,8
Cheung 2019.pdf,437438,NRT + brief advice,2243,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,36.2,22,14.8,Hong Kong,0,0,0,50,26.10,PP,0,1,,,8
Chouinard 2005 (c) primary paper.pdf,263082,Usual care,162,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57.25,37.5,-,Canada,0,0,0,56,26.10,C,1,0,,,12.7
Chouinard 2005 (c) primary paper.pdf,263082,Inpatient counseling only,161,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,56.5,19.6,-,Canada,0,0,0,56,26.10,C,1,0,,,24.5
Chouinard 2005 (c) primary paper.pdf,263082,Inpatient counseling with telephone follow-up,160,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,54,23.2,-,Canada,0,0,0,56,26.10,C,1,0,,,24.5
Ciccolo 2011.pdf,263084,Resistance training,163,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,36.5,52,18,-,0,0,0,13,26.10,C,1,0,,,15
Ciccolo 2011.pdf,263084,Contact control,164,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,36.5,52,18,-,0,0,0,12,26.10,C,1,0,,,8
Clark-2004.pdf,263085,Internet resources,165,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,57.8,46,-,-,0,0,0,85,4.35,PP,0,1,,,5
Clark-2004.pdf,263085,Standard materials,166,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,57,52,-,-,0,0,0,86,4.35,PP,0,1,,,10
Clyde 2018.pdf,437496,NRT,2597,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,47.68,45.3,22.82,-,0,0,1,164,52.00,PP,0,1,,,15.6
Clyde 2018.pdf,437496,Varenicline,2595,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,1,0,1,49.48,45.2,24.62,-,0,0,1,165,52.00,PP,0,1,,,15.6
Clyde 2018.pdf,437496,NRT+,2596,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,47.23,43.3,24.12,-,0,0,1,170,52.00,PP,0,1,,,15.6
Cobos-Campos 2017.pdf,436353,Control,2808,1,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,44.9,45.6,-,-,0,0,0,160,52.20,C,1,0,,,5.6
Cobos-Campos 2017.pdf,436353,Intervention,2807,0,1,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,45.1,42.5,-,-,0,0,0,160,52.20,C,1,0,,,16.25
Colby 2005.pdf,319574,Motivational interviewing (MI),623,0,1,0,1,0,1,1,1,0,0,1,1,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,16.3,71,10.5,-,0,0,0,43,26.10,PP,0,1,,,9
Colby 2005.pdf,319574,Brief advice (BA),624,0,1,0,0,1,0,0,0,0,0,1,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,16.3,71,10.5,-,0,0,0,42,26.10,PP,0,1,,,2
Coleman-Cowger 2018.pdf,437497,Intervention group,2326,0,1,0,0,0,0,1,1,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,26.3,-,9.5,-,0,0,0,64,26.10,PP,0,1,,,24
Coleman-Cowger 2018.pdf,437497,Control group,2327,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.6,-,7.7,-,0,0,0,64,26.10,PP,0,1,,,24
Cooney 2017.pdf,423066,CBT + NRT,2015,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,50.8,4.9,20.4,U.S.,0,0,1,41,26.10,PP,0,1,,,5
Cooney 2017.pdf,423066,CBT + NRT + CM,2014,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,48.9,2.4,20.1,U.S.,0,0,1,42,26.10,PP,0,1,,,12
Cooperman 2018.pdf,437499,Control group,2182,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,57,-,-,0,0,0,42,26.10,PP,0,1,,,2
Cooperman 2018.pdf,437499,Intervention group,2181,0,1,0,1,0,1,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,59,-,-,0,0,0,41,26.10,PP,0,1,,,2
Cottraux 1983.pdf,321094,Behavior therapy,688,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,-,-,31.46,France,0,0,0,138,8.70,NCS,0,0,,,7
Cottraux 1983.pdf,321094,Control,691,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,30.97,France,0,0,0,140,8.70,NCS,0,0,,,6
Cottraux 1983.pdf,321094,Acupuncture,689,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,31.3,France,0,0,0,140,8.70,NCS,0,0,,,1
Cottraux 1983.pdf,321094,Placebo,690,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,-,-,31.55,France,0,0,0,140,8.70,NCS,0,0,,,13
Crane 2019.pdf,437440,Full Smoke Free app,2258,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.7,49.3,14.6,-,0,0,1,14228,13.05,C,1,0,,,1.6
Crane 2019.pdf,437440,Reduced Smoke Free app,2259,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29.1,48.8,14.8,-,0,0,1,13884,13.05,C,1,0,,,0.9
Cropsey 2008 (c) primary paper.pdf,263086,Behavioural intervention with nicotine replacement therapy,167,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,1,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33.8,-,-,United States,0,1,1,-,52.20,PP,0,1,,,14
Cropsey 2008 (c) primary paper.pdf,263086,Waitlist control,168,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.8,-,-,United States,0,1,1,289,52.20,PP,0,1,,,2.8
Cropsey 2015.pdf,423114,Counseling,2081,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,1,0,-,-,-,United States,0,0,0,-,12.00,PP,0,1,12,weeks,28.4
Cropsey 2015.pdf,423114,No counseling,2082,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,-,-,-,United States,0,0,0,-,12.00,PP,0,1,12,weeks,9.4
Cuckle 1984.pdf,296408,Control,778,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,719,52.20,NCS,0,0,,,11
Cuckle 1984.pdf,296408,Kit alone,777,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,643,52.20,NCS,0,0,,,14
Cuckle 1984.pdf,296408,Kit plus additional information,776,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,599,52.20,NCS,0,0,,,17
Cummings 1988.pdf,296410,Less structured plan + cold turkey,782,0,0,0,0,0,0,1,0,0,1,0,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,65,28,United States,0,0,0,1534,26.10,PP,0,1,,,18
Cummings 1988.pdf,296410,Less structured plan + gradual reduction,781,0,0,0,0,0,1,1,0,0,1,0,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,65,28,United States,0,0,0,1534,26.10,PP,0,1,,,18
Cummings 1988.pdf,296410,Control,783,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,65,28,United States,0,0,0,1534,26.10,PP,0,1,,,18
Cummings 1988.pdf,296410,Day-by-day plan + cold turkey,780,0,0,0,0,0,0,1,0,0,1,0,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,65,28,United States,0,0,0,1534,26.10,PP,0,1,,,18
Cummings 1988.pdf,296410,Day-by-day plan + gradual reduction,779,0,0,0,0,0,1,1,0,0,1,0,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,65,28,United States,0,0,0,1534,26.10,PP,0,1,,,18
Cummins 2016.pdf,423085,Patches plus counseling,1917,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,49.1,45.4,14.8,Guatemala,0,0,0,-,26.10,PP,0,1,,,22.1
Cummins 2016.pdf,423085,Counseling only,1918,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,49.6,42.9,14.7,Guatemala,0,0,0,-,26.10,PP,0,1,,,18
Cummins 2016.pdf,423085,Usual care,1920,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,49.7,43,14.8,Guatemala,0,0,0,-,26.10,PP,0,1,,,18.7
Cummins 2016.pdf,423085,Nicotine patches only,1919,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,51.1,41.9,14.1,Guatemala,0,0,0,-,26.10,PP,0,1,,,23.4
Curry 1988.pdf,321095,Absolute abstinence (AA - self help),1044,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.6,51,27.7,-,0,0,0,41,52.20,NCS,0,0,,,17
Curry 1988.pdf,321095,Relapse prevention (RP - group),692,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,40.6,51,27.7,-,0,0,0,24,52.20,NCS,0,0,,,25
Curry 1988.pdf,321095,Relapse prevention (RP - self help),1043,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.6,51,27.7,-,0,0,0,50,52.20,NCS,0,0,,,26
Curry 1988.pdf,321095,Absolute abstinence (AA - group),693,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,40.6,51,27.7,-,0,0,0,24,52.20,NCS,0,0,,,38
Curry 1995.pdf,296262,Control,467,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.2,48,17.1,-,0,0,0,324,52.20,C,1,0,,,3
Curry 1995.pdf,296262,Feedback,465,0,1,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.9,53,17.7,-,0,0,0,323,52.20,C,1,0,,,3
Curry 1995.pdf,296262,Phone,464,0,1,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,40.8,59,17.1,-,0,0,0,150,52.20,C,1,0,,,5
Curry 1995.pdf,296262,Booklet,466,0,1,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.3,53,17.2,-,0,0,0,327,52.20,C,1,0,,,2
Curry 2003.pdf,296341,Control,418,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33.6,-,12,-,0,0,0,147,52.20,PP,0,1,,,8
Curry 2003.pdf,296341,Intervention,417,0,0,0,1,0,0,1,0,0,0,1,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,34.2,-,12.2,-,0,0,0,156,52.20,PP,0,1,,,17
Curry_1991_Evaluation of intrinsic and extrinsic motivation_10.10370022-006X.59.2.318.pdf,263040,Both,102,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.3,65,25.1,-,0,0,0,304,52.20,PP,0,1,,,4
Curry_1991_Evaluation of intrinsic and extrinsic motivation_10.10370022-006X.59.2.318.pdf,263040,Extrinstic,104,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.2,64,24.2,-,0,0,0,304,52.20,PP,0,1,,,4
Curry_1991_Evaluation of intrinsic and extrinsic motivation_10.10370022-006X.59.2.318.pdf,263040,Intrinsic,103,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.3,64,25,-,0,0,0,304,52.20,PP,0,1,,,10
Curry_1991_Evaluation of intrinsic and extrinsic motivation_10.10370022-006X.59.2.318.pdf,263040,Control,105,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.7,65,24.5,-,0,0,0,305,52.20,PP,0,1,,,5
Dallery 2017.pdf,423067,abstinent contingent group,2016,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.7,56,17.8,United States,0,0,0,48,26.10,PP,0,1,,,22.9
Dallery 2017.pdf,423067,submission contingent,2017,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.9,54,18.3,United States,0,0,0,46,26.10,PP,0,1,,,13
Dallery-2013-Internet-based contingency manage.pdf,263090,Contingent group,169,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.3,49,20.4,Colombia,0,0,0,39,26.10,PP,0,1,,,8
Dallery-2013-Internet-based contingency manage.pdf,263090,Non-contingent group,170,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.1,47,20.6,Colombia,0,0,0,38,26.10,PP,0,1,,,15.8
Dalum 2012.pdf,319575,Intervention,625,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,-,-,-,Denmark,0,0,0,173,60.90,PP,0,1,,,7.5
Dalum 2012.pdf,319575,Control,626,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,Denmark,0,0,0,196,60.90,PP,0,1,,,7.1
Danaher 2019.pdf,436356,QuitOnline,2685,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,45.6,78.5,17.9,US,0,0,0,638,26.10,PP,0,1,,,19.3
Danaher 2019.pdf,436356,MobileQuit,2684,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,44.2,77.6,17.1,US,0,0,0,633,26.10,PP,0,1,,,24.6
Davis 1992.pdf,296417,quitting times,787,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,-,0,0,0,630,26.10,PP,0,1,,,10
Davis 1992.pdf,296417,cleaning the air,788,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,-,0,0,0,630,26.10,PP,0,1,,,10
Davis 1992.pdf,296417,Freedom from smoking for you and your family,786,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,-,0,0,0,630,26.10,PP,0,1,,,9
Davis 2014 (a) primary paper (c).pdf,263093,Mindfulness Training for Smokers (MTS),171,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,1,1,1,0,1,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,41.65,50,15.75,-,0,0,0,105,24.00,PP,0,1,,,10
Davis 2014 (a) primary paper (c).pdf,263093,Control,172,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41.65,50,15.75,-,0,0,0,91,24.00,PP,0,1,,,5
Dedert 2018.pdf,437501,Placebo patch,2203,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44.5,48,-,-,0,0,1,44,26.10,PP,0,1,,,32
Dedert 2018.pdf,437501,Active patch,2202,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,43,-,-,0,0,1,37,26.10,PP,0,1,,,5
Dedert 2019.pdf,437442,Present-focused smoking cessation (PS),2188,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,1,1,0,0,1,0,0,1,1,1,0,0,0,0,1,0,0,1,0,53.3,24,16,-,0,0,0,25,26.10,PP,0,1,,,16
Dedert 2019.pdf,437442,Cognitive processing therapy and smoking cessation (CPTS),2187,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,1,1,0,1,0,0,1,0,0,1,0,43.1,7,13.9,-,0,0,0,15,26.10,PP,0,1,,,13
Dennis 2016.pdf,423136,Active patch,2045,0,1,0,0,0,0,1,1,0,0,1,0,0,1,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42.3,55,-,-,0,0,0,32,26.10,PP,0,1,,,0
Dennis 2016.pdf,423136,Placebo patch,2046,0,1,0,0,0,0,1,1,0,0,1,0,0,1,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42.8,53,-,-,0,0,0,31,26.10,PP,0,1,,,0
Dent-2009 primary paper.pdf,263096,Pharmacist-delivered program,173,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,56.7,7,18.9,US,0,0,0,50,26.10,PP,0,1,,,28
Dent-2009 primary paper.pdf,263096,Standard care over telephone,174,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,55,7,20.1,US,0,0,0,51,26.10,PP,0,1,,,11.8
Dickson Spillmann 2013 (c) primary paper.pdf,263098,Relaxation sessions,176,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,36.9,49.5,-,Switzerland,0,0,0,107,26.10,PP,0,1,,,17.8
Dickson Spillmann 2013 (c) primary paper.pdf,263098,Hypnosis sessions,175,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,38,44.8,-,Switzerland,0,0,0,116,26.10,PP,0,1,,,14.7
Dijkstra 1998a.pdf,296419,No information (CO),869,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.7,59,20.3,Netherlands,0,0,0,250,60.90,C,1,0,,,1.6
Dijkstra 1998a.pdf,296419,Self-efficacy information (SE),792,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,Netherlands,0,0,0,244,60.90,C,1,0,,,3.3
Dijkstra 1998a.pdf,296419,Outcome information (OC),793,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,Netherlands,0,0,0,247,60.90,C,1,0,,,2.4
Dijkstra 1998a.pdf,296419,Both sorts of information (BO),791,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,Netherlands,0,0,0,249,60.90,C,1,0,,,4.8
Dijkstra 1999.pdf,296422,No-information control (CO),797,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.7,62.8,21.5,Netherlands,0,0,0,182,26.10,PP,0,1,,,5.5
Dijkstra 1999.pdf,296422,Self-help guide (SHG),796,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.7,62.8,21.5,Netherlands,0,0,0,201,26.10,PP,0,1,,,3.5
Dijkstra 1999.pdf,296422,Multiple-tailored intevention (MT),794,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.7,62.8,21.5,Netherlands,0,0,0,187,26.10,PP,0,1,,,3.2
Dijkstra 1999.pdf,296422,Single-tailored intervention (ST),795,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.7,62.8,21.5,Netherlands,0,0,0,180,26.10,PP,0,1,,,4.4
Dijkstra_1998_Tailored Interventions to Communicate Stage-Matched Information_10.10370022-006X.66.3.549.pdf,263042,Self-efficacy-enhancing information only,110,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,ghout The Netherlands.,0,0,0,385,10.00,PP,0,1,10,weeks,8
Dijkstra_1998_Tailored Interventions to Communicate Stage-Matched Information_10.10370022-006X.66.3.549.pdf,263042,Outcome information only,109,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,ghout The Netherlands.,0,0,0,384,10.00,PP,0,1,10,weeks,4
Dijkstra_1998_Tailored Interventions to Communicate Stage-Matched Information_10.10370022-006X.66.3.549.pdf,263042,Control,111,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.7,59,20.3,ghout The Netherlands.,0,0,0,385,10.00,PP,0,1,10,weeks,3.2
Dijkstra_1998_Tailored Interventions to Communicate Stage-Matched Information_10.10370022-006X.66.3.549.pdf,263042,Both types of information,108,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.7,59,20.3,ghout The Netherlands.,0,0,0,386,10.00,PP,0,1,10,weeks,8
Dogar 2018.pdf,437503,Varenicline,2200,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,49.9,15.8,12.3,multinational,0,1,1,253,25.00,PP,0,1,,,4.7
Dogar 2018.pdf,437503,Placebo,2201,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,48.4,16,12.7,multinational,0,1,1,257,25.00,PP,0,1,,,4.3
Drummond 2014.pdf,423068,Usual care,1925,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52.3,42,19,United States,0,0,0,26,26.10,PP,0,1,,,4
Drummond 2014.pdf,423068,Contingency management and lung age,1922,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49.2,38,21,United States,0,0,0,24,26.10,PP,0,1,,,0
Drummond 2014.pdf,423068,Lung age,1924,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46.1,42,17,United States,0,0,0,24,26.10,PP,0,1,,,0
Drummond 2014.pdf,423068,Contingency management,1923,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.2,65,12,United States,0,0,0,26,26.10,PP,0,1,,,14
Duffy 2006.pdf,296344,Usual care,422,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,58,9,-,-,0,1,1,91,26.10,C,1,0,,,31
Duffy 2006.pdf,296344,Intervention,421,0,0,1,0,0,1,1,0,0,1,1,0,0,1,0,1,1,0,1,1,0,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,1,56,23,-,-,0,1,1,93,26.10,C,1,0,,,47
Durmaz 2019.pdf,437445,WhatsApp arm,2191,0,0,0,1,0,1,1,1,0,0,1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,39.3,36.4,-,-,1,0,0,44,6.00,PP,0,1,,,40.9
Durmaz 2019.pdf,437445,Control arm,2192,1,0,0,1,0,1,1,1,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,39.3,40.9,-,-,1,0,0,88,6.00,PP,0,1,,,23.9
Ebbert JADA 2007.pdf,296264,brief smoking cessation counseling with referrals to tobacco use quitline,468,0,0,0,0,0,1,1,0,0,0,1,0,1,1,1,1,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,-,-,-,-,1,0,0,60,26.10,PP,0,1,,,25
Ebbert JADA 2007.pdf,296264,brief smoking cessation counseling,469,0,0,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,-,-,-,-,1,0,0,22,26.10,PP,0,1,,,27.3
El Hajj 2017.pdf,436357,Intervention group,2643,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,-,1.8,21.6,Qatar,1,0,0,167,52.20,C,1,0,,,12.6
El Hajj 2017.pdf,436357,Control group,2644,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,-,2.7,23.5,Qatar,1,0,0,147,52.20,C,1,0,,,4.1
Elkins 2006.pdf,263102,Hypnotherapy,177,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,1,0,43.7,60,22.2,-,0,0,0,20,26.00,PP,0,1,,,40
Elkins 2006.pdf,263102,Control,178,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.7,80,25.7,-,0,0,0,20,26.00,PP,0,1,,,0
Ellerbeck 2009 (c) primary paper.pdf,263104,High-intensity disease management (HDM),179,0,1,0,1,0,1,1,0,0,0,1,1,0,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,46.4,60.2,22.9,-,1,1,1,244,104.40,PP,0,1,,,14.8
Ellerbeck 2009 (c) primary paper.pdf,263104,Pharmacotherapy Management (PM),181,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,47.1,57.6,24.3,-,1,1,1,244,104.40,PP,0,1,,,13.5
Ellerbeck 2009 (c) primary paper.pdf,263104,Moderate-intensity disease management (MDM),180,0,1,0,0,0,1,1,0,0,0,1,1,0,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,48.2,57.8,23.8,-,1,1,1,238,104.40,PP,0,1,,,14.7
Ellerbeck 2019.pdf,437446,Counseling with Care Coordination (CCC),2209,0,1,0,0,0,1,1,1,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,50.6,63,19.3,-,0,0,1,296,52.20,PP,0,1,,,19.3
Ellerbeck 2019.pdf,437446,Counseling Only (C),2210,0,1,0,0,0,1,1,1,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,51,64,19.7,-,0,0,1,284,52.20,PP,0,1,,,16.9
Emmons J Clin Oncol 2009.pdf,296266,peer-delivered telephone counseling (PC),470,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,48,-,-,0,1,1,383,7.83,PP,0,1,,,20.6
Emmons J Clin Oncol 2009.pdf,296266,self help (SH),471,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,31,46,-,-,0,1,1,385,7.83,PP,0,1,,,17.6
Espada 2015.pdf,319576,Project EX,627,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.4,53.3,200,Spain,0,0,0,35,26.10,PP,0,1,,,4.9
Espada 2015.pdf,319576,Control,628,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.4,53.3,200,Spain,0,0,0,65,26.10,PP,0,1,,,0
Etringer 1984.pdf,321101,Enriched cohesiveness x satiation,700,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,36.4,-,24.7,-,0,0,0,72,52.20,NCS,0,0,,,32
Etringer 1984.pdf,321101,Standard cohesiveness x nicotine fading,701,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.4,-,24.7,-,0,0,0,72,52.20,NCS,0,0,,,40
Etringer 1984.pdf,321101,Standrad cohesiveness x satiation,702,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.4,-,24.7,-,0,0,0,72,52.20,NCS,0,0,,,6
Etringer 1984.pdf,321101,Enriched cohesiveness x nicotine fading,699,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,36.4,-,24.7,-,0,0,0,72,52.20,NCS,0,0,,,45
Etter 2004.pdf,296423,Programme,798,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,52,20,Switzerland,0,0,0,1467,100.05,PP,0,1,,,11.1
Etter 2004.pdf,296423,Control,799,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,52,20,Switzerland,0,0,0,1467,100.05,PP,0,1,,,10.5
Etter 2016.pdf,423069,Control group,1982,1,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,56,16,multinational,0,0,0,404,78.30,C,1,0,,,3.7
Etter 2016.pdf,423069,Incentive group,1981,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,47,1,multinational,0,0,0,401,78.30,C,1,0,,,9.5
Evins 2014.pdf,423086,Varenicline + CBT,1926,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,-,-,-,-,0,1,1,40,64.00,PP,0,1,,,45
Evins 2014.pdf,423086,Placebo + CBT,1927,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,-,-,-,-,0,1,1,47,64.00,PP,0,1,,,13
Feeney 2001.pdf,263107,Stanford Heart Attack Staying Free (SF),182,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,1,0,1,52.89,24,-,-,0,0,0,79,52.20,NCS,0,0,,,39
Feeney 2001.pdf,263107,Usual Care,183,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,55.13,29,-,-,0,0,0,62,52.20,NCS,0,0,,,2
Fiore 2004.pdf,296268,Patch + Committed Quitters (CQ),477,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,39.6,58.4,21.7,-,0,0,0,-,4.35,PP,0,1,,,6.2
Fiore 2004.pdf,296268,Patch Only,478,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,39.6,58.4,21.7,-,0,0,0,-,4.35,PP,0,1,,,6.6
Fiore 2004.pdf,296268,Patch +  Committed Quitters (CQ) + counselling,476,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,39.6,58.4,21.7,-,0,0,0,-,4.35,PP,0,1,,,10.4
Forinash 2018.pdf,437507,Text-messaging,2245,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,1,1,1,0,0,0,-,-,-,-,1,0,0,14,2.00,PP,0,1,,,57.1
Forinash 2018.pdf,437507,Standard of care,2246,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,-,-,-,-,1,0,0,16,2.00,PP,0,1,,,31.3
Fortmann 1995.pdf,296424,Gum + materials,800,0,1,0,0,0,1,1,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.3,41.9,20.1,-,0,0,0,260,52.20,PP,0,1,,,21
Fortmann 1995.pdf,296424,Incentive only,802,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.8,41.8,20.1,-,0,0,0,261,52.20,PP,0,1,,,16
Fortmann 1995.pdf,296424,Materials only,801,0,1,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.9,42,20.1,-,0,0,0,261,52.20,PP,0,1,,,16
Fortmann 1995.pdf,296424,Gum only,803,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40.6,42,20.1,-,0,0,0,262,52.20,PP,0,1,,,21
Frandsen-2012.pdf,263292,Minimal smoking cessation intervention,148,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,-,48.9,-,Denmark,0,0,0,45,26.10,NCS,0,0,,,28.9
Frandsen-2012.pdf,263292,Intensive smoking cessation intervention,147,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,1,1,0,1,1,1,0,0,0,1,0,1,1,0,0,0,0,0,1,0,0,0,1,-,34.7,-,Denmark,0,0,0,49,26.10,NCS,0,0,,,32.7
Fraser 2017.pdf,423070,Control,1984,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,60,17,-,0,0,0,952,26.10,PP,0,1,,,13.76
Fraser 2017.pdf,423070,Incentive,1983,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,60,17,-,0,0,0,948,26.10,PP,0,1,,,21.62
Froelicher 2004b.pdf,296346,Usual care group (UG),424,1,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,-,-,6,-,0,1,1,135,130.50,PP,0,1,,,50
Froelicher 2004b.pdf,296346,Intervention group (IG),423,0,1,0,0,0,0,1,0,0,0,1,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,-,-,6,-,0,1,1,142,130.50,PP,0,1,,,50
Froelicher 2010.pdf,263109,Control group (CG),185,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,46.5,64.7,11.35,United States,0,0,0,34,52.20,PP,0,1,,,5.3
Froelicher 2010.pdf,263109,CG care plus tobacco industry and media (IAM),184,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,46.7,80.8,11.35,United States,0,0,0,26,52.20,PP,0,1,,,15.8
Garcia 2000.pdf,321099,Control,698,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.87,-,5.53,Spain,0,0,0,48,52.20,PP,0,1,,,2
Garcia 2000.pdf,321099,5-session,696,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,30.93,-,25.67,Spain,0,0,0,31,52.20,PP,0,1,,,38.7
Garcia 2000.pdf,321099,Manual only,697,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35.45,-,25.8,Spain,0,0,0,33,52.20,PP,0,1,,,15.1
Garcia 2000.pdf,321099,5-session + manual,695,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,32.48,-,25.04,Spain,0,0,0,25,52.20,PP,0,1,,,48
Garcia 2000.pdf,321099,10-session,694,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,32,-,29.44,Spain,0,0,0,25,52.20,PP,0,1,,,16
Garrison 2018.pdf,436358,Experience Sampling-Only (ES),2654,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.7,-,16.2,-,0,0,0,182,26.10,PP,0,1,,,12.1
Garrison 2018.pdf,436358,Mobile Mindfulness Training With Experience Sampling (MMT-ES),2653,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.3,-,16,-,0,0,0,143,26.10,PP,0,1,,,9.8
Gifford 2011.pdf,321104,Combined treatment,703,0,1,1,0,0,1,0,0,0,1,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,45.75,58.7,24.01,-,0,0,0,130,52.20,PP,0,1,,,31.6
Gifford 2011.pdf,321104,Medication only,704,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,46.16,58.7,24.23,-,0,0,0,173,52.20,PP,0,1,,,17.5
Gilbert 2006.pdf,296269,Control,480,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,39.1,64.2,-,UK,0,0,0,704,52.20,C,1,0,,,9.5
Gilbert 2006.pdf,296269,Repeated contact,479,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,39.6,67.2,-,UK,0,0,0,753,52.20,C,1,0,,,9.3
Gilbert 2013.pdf,296425,Intervention,804,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,55.1,17.8,UK,0,0,0,3340,26.10,C,1,0,,,3.2
Gilbert 2013.pdf,296425,Control,805,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.8,56.8,17.7,UK,0,0,0,3357,26.10,C,1,0,,,2.7
Gilbody 2015.pdf,263112,Bespoke smoking cessation,186,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,47.3,30,26.5,UK,0,0,0,33,52.20,NCS,0,0,,,26
Gilbody 2015.pdf,263112,Usual care,187,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,46.4,49,23.3,UK,0,0,0,35,52.20,NCS,0,0,,,16
Gilbody 2019.pdf,437448,Intervention,2218,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,46.5,40,24.7,UK,0,0,0,223,52.20,PP,0,1,,,15
Gilbody 2019.pdf,437448,Control,2219,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.5,43,23.2,UK,0,0,0,219,52.20,PP,0,1,,,10
Glasgow 1981.pdf,296427,Danaher & Lichtenstein - self-administered,808,0,1,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.3,-,32,-,0,0,0,13,26.10,PP,0,1,,,8
Glasgow 1981.pdf,296427,Danaher & Lichtenstein - therapist administered,806,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,37.3,-,32,-,0,0,0,14,26.10,PP,0,1,,,25
Glasgow 1981.pdf,296427,IQuit kit - self-administered,811,0,1,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.3,-,32,-,0,0,0,15,26.10,PP,0,1,,,8
Glasgow 1981.pdf,296427,IQuit kit - therapist administered,810,0,1,0,0,0,1,0,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,37.3,-,32,-,0,0,0,14,26.10,PP,0,1,,,8
Glasgow 1981.pdf,296427,Pomerleau & Pomerleau - therapist administered,807,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,37.3,-,32,-,0,0,0,6,26.10,PP,0,1,,,37
Glasgow 1981.pdf,296427,Pomerleau & Pomerleau - self-administered,809,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.3,-,32,-,0,0,0,13,26.10,PP,0,1,,,0
Gonzalvez 2015.pdf,319578,Project Ex,629,0,1,0,0,0,1,0,0,0,0,0,1,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.03,49.3,-,Spain,0,0,0,572,4.35,PP,0,1,,,22.2
Gonzalvez 2015.pdf,319578,Control,630,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.03,49.3,-,Spain,0,0,0,393,4.35,PP,0,1,,,15.2
Graham 2011.pdf,296270,Enhanced internet (EI),482,0,0,0,0,0,1,1,0,0,0,1,1,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.9,51.1,20,US,0,0,0,651,78.30,PP,0,1,,,17.4
Graham 2011.pdf,296270,Basic internet (BI),483,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.9,51.1,20,US,0,0,0,679,78.30,PP,0,1,,,19
Graham 2011.pdf,296270,Enhanced internet + phone (EI+P),481,0,0,0,0,0,1,1,0,0,0,1,1,1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,35.9,51.1,20,US,0,0,0,675,78.30,PP,0,1,,,19.6
Graham 2018.pdf,437509,WEB + NRT,2250,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,1313,39.15,PP,0,1,,,13.9
Graham 2018.pdf,437509,WEB + SN,2251,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,1323,39.15,PP,0,1,,,11
Graham 2018.pdf,437509,WEB + SN + NRT,2249,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,1317,39.15,PP,0,1,,,14
Graham 2018.pdf,437509,WEB,2252,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,1337,39.15,PP,0,1,,,12.4
Grant 2003.pdf,280756,Education and group therapy,188,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,-,-,United States,0,0,0,20,52.20,pp,0,1,,,18.2
Grant 2003.pdf,280756,Usual care,189,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,15,-,United States,0,0,0,20,52.20,pp,0,1,,,60
Greenberg 1978.pdf,319580,Attitude,633,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,2,21.75,NCS,0,0,,,29
Greenberg 1978.pdf,319580,Control,868,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,18,21.75,NCS,0,0,,,6
Greenberg 1978.pdf,319580,Scare,631,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,19,21.75,NCS,0,0,,,16
Greenberg 1978.pdf,319580,Fact,632,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,20,21.75,NCS,0,0,,,20
Gulliver 2008.pdf,263117,Motivational interviewing (MI),194,0,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,49.06,-,23,United States,0,0,0,67,26.10,PP,0,1,,,6
Gulliver 2008.pdf,263117,Motivational Interviewing plus instruction in deep breathing (MI/BI),193,0,1,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,49.64,4.09999999999999,23,United States,0,0,0,74,26.10,PP,0,1,,,6.8
Gulliver 2008.pdf,263117,Motivational Interviewing plus instruction spirometer (MI/IS),192,0,1,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,47.5,6,23,United States,0,0,0,67,26.10,PP,0,1,,,4.5
Guo 2014.pdf,319582,Control,635,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16.08,20,4.91,Taiwan,0,0,0,49,17.40,NCS,0,0,,,2.04
Guo 2014.pdf,319582,Intervention,634,0,1,0,0,0,1,1,1,0,1,1,1,0,0,1,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,16.05,12.82,5.1,Taiwan,0,0,0,53,17.40,NCS,0,0,,,20.75
Hajek 2019.pdf,437450,E-cigarette group,2241,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,-,48.2,-,United States,0,0,0,438,52.00,C,1,0,,,18
Hajek 2019.pdf,437450,Nicotine-replacement group,2242,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,-,47.8,-,United States,0,0,0,446,52.00,C,1,0,,,9.9
Hall 1996.pdf,321114,Standard smoking intervention for major depressive disorder (MDD) x placebo,708,0,1,0,0,0,1,0,0,0,1,1,0,0,1,0,0,1,1,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.7,52,23.8,United States,0,0,0,74,52.00,PP,0,1,,,22
Hall 1996.pdf,321114,mood management (MM) x 2mg nicotine gum,705,0,1,0,0,0,1,1,0,0,1,1,0,0,0,0,1,1,1,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.7,52,23.8,United States,0,0,0,21,52.00,PP,0,1,,,24
Hall 1996.pdf,321114,mood management (MM) x placebo,706,0,1,0,0,0,1,1,0,0,1,1,0,0,0,0,0,1,1,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.7,52,23.8,United States,0,0,0,83,52.00,PP,0,1,,,25
Hall 1996.pdf,321114,Standard smoking intervention for major depressive disorder (MDD) x 2mg nicotine gum,707,0,1,0,0,0,1,0,0,0,1,1,0,0,1,0,1,1,1,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.7,52,23.8,United States,0,0,0,23,52.00,PP,0,1,,,17
Hall 2002 (c) primary paper.pdf,263120,Placebo + medical management (MM),204,0,1,0,0,0,1,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,43.4,40.5,23,-,0,0,0,-,52.00,PP,0,1,,,11
Hall 2002 (c) primary paper.pdf,263120,Buproprion + psychological intervention (PI),199,0,1,0,0,0,0,1,1,0,0,0,0,0,1,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,37.9,46,22.5,-,0,0,0,-,52.00,PP,0,1,,,24
Hall 2002 (c) primary paper.pdf,263120,Placebo + psychological intervention (PI),203,0,1,0,0,0,0,1,1,0,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,39.3,47.2,22.2,-,0,0,0,-,52.00,PP,0,1,,,17
Hall 2002 (c) primary paper.pdf,263120,Bupropion Hydrochloride + medical management (MM),200,0,1,0,0,0,1,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,37.1,41.7,19.8,-,0,0,0,-,52.00,PP,0,1,,,25
Hall 2002 (c) primary paper.pdf,263120,Nortriptyline + psychological intervention (PI),201,0,1,0,0,0,0,1,1,0,0,0,0,0,1,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,40.9,45.7,20.2,-,0,0,0,-,52.00,PP,0,1,,,17
Hall 2002 (c) primary paper.pdf,263120,Nortriptyline Hydrochloride + medical management (MM),202,0,1,0,0,0,1,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,37.8,44.7,20.9,-,0,0,0,-,52.00,PP,0,1,,,18
Hall 2004 (c) primary paper.pdf,263122,Extended Placebo,207,0,1,0,0,0,1,1,1,0,1,1,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,1,0,38.9,46.3,18.7,-,0,0,0,30,52.00,PP,0,1,,,42
Hall 2004 (c) primary paper.pdf,263122,Brief Nortriptyline,206,0,1,0,0,0,1,1,1,0,1,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,1,0,36.1,38.5,20.4,-,0,0,0,34,52.00,PP,0,1,,,18
Hall 2004 (c) primary paper.pdf,263122,Brief Placebo,208,0,1,0,0,0,1,1,1,0,1,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,1,0,38.8,42.5,18.8,-,0,0,0,37,52.00,PP,0,1,,,30
Hall 2004 (c) primary paper.pdf,263122,Extended Nortriptyline,205,0,1,0,0,0,1,1,1,0,1,1,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,1,1,0,1,0,40.2,37.5,18.8,-,0,0,0,36,52.00,PP,0,1,,,50
Hall 2006 (c) primary paper.pdf,263125,Staged care intervention,209,0,1,0,0,0,1,1,0,1,0,1,0,0,1,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41.5,68.1,15.8,-,0,0,0,163,78.30,PP,0,1,,,18.4
Hall 2006 (c) primary paper.pdf,263125,Brief contact control,210,1,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42.2,71.1,15.3,-,0,0,0,159,78.30,PP,0,1,,,13.21
Hall 2009 primary paper (c).pdf,263127,Extended combined,211,0,1,1,0,0,0,1,0,0,1,1,0,0,0,1,1,1,1,1,0,0,0,1,1,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,56.7,40,20.5,-,0,0,0,87,104.00,PP,0,1,,,45
Hall 2009 primary paper (c).pdf,263127,Extended Nicotine Replacement Therapy (NRT),213,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,56.7,40,20.5,-,0,0,0,87,104.00,PP,0,1,,,40
Hall 2009 primary paper (c).pdf,263127,Extended cognitive behavioural therapy (CBT),212,0,1,0,0,0,0,1,0,0,1,1,0,0,0,1,1,1,1,1,0,0,0,1,1,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,56.7,40,20.5,-,0,0,0,84,104.00,PP,0,1,,,55
Hall 2009 primary paper (c).pdf,263127,Brief treatment,214,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,1,1,0,0,0,0,0,1,1,1,0,1,0,0,1,0,0,0,0,56.7,40,20.5,-,0,0,0,85,104.00,PP,0,1,,,36
Hall 2018.pdf,437511,Extended innovative system intervention (E-ISI),2256,0,1,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,1,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,40,22.4,14.8,-,0,0,0,156,78.30,PP,0,1,,,16.5
Hall 2018.pdf,437511,Standard Treatment Control (STC),2257,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.6,25,14.6,-,0,0,0,156,78.30,PP,0,1,,,14.3
Halpern 2018.pdf,423072,Free e-cigarettes,1989,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,49.8,-,-,0,0,0,1199,26.10,C,1,0,,,1
Halpern 2018.pdf,423072,Usual care,1991,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,51,-,-,0,0,0,813,26.10,C,1,0,,,0.1
Halpern 2018.pdf,423072,Rewards plus Free Cessation Aids,1988,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,1,1,1,0,0,1,0,0,1,1,1,1,0,0,0,0,0,0,0,0,-,51.3,-,-,0,0,0,1198,26.10,C,1,0,,,2
Halpern 2018.pdf,423072,Free Cessation Aids,1990,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,1,1,1,0,0,1,0,0,1,1,1,1,0,0,0,0,0,0,0,0,-,52.4,-,-,0,0,0,1588,26.10,C,1,0,,,0.5
Halpern 2018.pdf,423072,Redeemable Deposit plus Free Cessation Aids,1987,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,-,51.2,-,-,0,0,0,1208,26.10,C,1,0,,,2.9
Halpin 2006.pdf,296271,drugs only,486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,1,-,64,-,United States,0,0,0,126,34.80,PP,0,1,,,19
Halpin 2006.pdf,296271,drugs and counseling,485,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,64,-,United States,0,0,0,140,34.80,PP,0,1,,,13
Halpin 2006.pdf,296271,drugs if counseling,484,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,70,-,United States,0,0,0,122,34.80,PP,0,1,,,18
Hanioka 2010.pdf,263132,Counseling + Nicotine Replacement Therapy,226,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,-,-,-,Japan,0,0,0,33,52.20,C,1,0,,,36.4
Hanioka 2010.pdf,263132,Control,227,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,Japan,0,0,0,23,52.20,C,1,0,,,13
Hanssen 2007.pdf,296351,Control,426,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,60.9,23.5,-,Norway,0,0,0,61,26.10,NCS,0,0,,,40.8
Hanssen 2007.pdf,296351,Intervention,425,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,59.5,15.4,-,Norway,0,0,0,77,26.10,NCS,0,0,,,60
Hanssen 2009.pdf,296272,Control,488,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,60,23,-,Norway,0,0,0,132,78.30,NCS,0,0,,,53
Hanssen 2009.pdf,296272,Intervention,487,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,59,15,-,Norway,0,0,0,156,78.30,NCS,0,0,,,54
Harris 2010.pdf,319583,Motivational Interviewing for smoking,636,0,1,0,1,0,1,0,1,0,0,1,1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19.4,35.5,3.4,-,0,0,0,245,26.10,PP,0,1,,,20.4
Harris 2010.pdf,319583,Motivational Interviewing for fruits/vegetables,637,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19.5,57.5,3.6,-,0,0,0,207,26.10,PP,0,1,,,24.6
Harris 2015.pdf,423236,Contingency Management (CM),2116,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,-,9.45,-,0,0,0,7,end of pregnancy,PP,0,1,,,28.57
Harris 2015.pdf,423236,Smoking Cessation for Healthy Births (SCHB),2115,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,24.2,-,13.69,-,0,0,0,10,end of pregnancy,PP,0,1,,,30
Hasan 2014.pdf,263133,Hypnotherapy,230,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,55,61,19.8,United States,0,0,0,41,26.00,PP,0,1,,,36.6
Hasan 2014.pdf,263133,Nicotine Replacement Therapy (NRT),229,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,55.3,46.2,21.2,United States,0,0,0,39,26.00,PP,0,1,,,18
Hasan 2014.pdf,263133,Nicotine Replacement Therapy (NRT) with hypnotherapy,228,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,1,0,0,1,1,0,1,1,1,0,0,1,0,0,1,0,0,0,0,1,0,1,0,0,0,0,54.4,36.8,20.5,United States,0,0,0,38,26.00,PP,0,1,,,34.2
Haug_1994_Is smoking intervention in general practice.pdf,252889,Intervention & Not-Pregnant,32,0,1,0,0,0,0,1,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,-,Norway,0,0,0,154,78.30,PP,0,1,18,months,20
Haug_1994_Is smoking intervention in general practice.pdf,252889,Intervention & Pregnant,31,0,1,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,-,Norway,0,0,0,244,78.30,PP,0,1,18,months,15
Haug_1994_Is smoking intervention in general practice.pdf,252889,Control & Pregnant,33,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,Norway,0,0,0,97,78.30,PP,0,1,18,months,7
Haug_1994_Is smoking intervention in general practice.pdf,252889,Control & Not-Pregnant,34,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,Norway,0,0,0,109,78.30,PP,0,1,18,months,7
Hayes 2018.pdf,423087,Control,1929,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,291,13.05,PP,0,1,,,14.4
Hayes 2018.pdf,423087,Treatment,1928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,286,13.05,PP,0,1,,,20.3
Heil 2008(c) primary paper.pdf,263134,Contingent-voucher condition,231,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25.3,-,7,-,0,0,0,37,24.00,PP,0,1,,,8
Heil 2008(c) primary paper.pdf,263134,Non-contingent-voucher condition,232,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23.4,-,7,-,0,0,0,40,24.00,PP,0,1,,,3
Hennrikus 2010.pdf,263140,Minimal intervention,237,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,60.7,12,17.5,United States,0,0,1,59,26.10,PP,0,1,,,6.8
Hennrikus 2010.pdf,263140,Intensive intervention,236,0,1,0,1,0,1,1,0,0,0,1,0,1,1,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,59.8,17,18.8,United States,0,0,1,61,26.10,PP,0,1,,,21.3
Herbec 2014.pdf,423237,MumsQuit,2117,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,27.6,-,14.6,UK,0,0,1,99,8.00,C,1,0,,,28.3
Herbec 2014.pdf,423237,Brief-advice control website,2118,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,28.1,-,14.7,UK,0,0,1,101,8.00,C,1,0,,,20.8
Hickman 2015.pdf,263141,Usual care,239,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.5,32,19.3,Mexico,0,0,1,51,52.20,PP,0,1,,,16.7
Hickman 2015.pdf,263141,Intervention,238,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39.5,32,19.3,Mexico,0,0,1,49,52.20,PP,0,1,,,26.2
Hicks 2017.pdf,423088,QUIT4EVER,1930,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,0,1,1,0,0,1,1,1,0,1,0,0,0,0,0,0,0,53.2,80,17,-,0,0,0,5,26.10,C,1,0,,,0
Hicks 2017.pdf,423088,Contact control,1931,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,0,1,1,0,0,1,1,1,0,1,0,0,0,0,0,0,0,54.3,50,18.2,-,0,0,0,6,26.10,C,1,0,,,0
Hilberink_2005_Smoking cessation in patients with COPD_10.1016j.ypmed.2005.08.003.pdf,252890,Smoking-Cessation Counselling (SMOCC),35,0,0,0,0,0,1,1,0,1,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,1,58,53.7,-,Netherlands,0,0,0,244,26.10,PP,0,1,6,months,16
Hilberink_2005_Smoking cessation in patients with COPD_10.1016j.ypmed.2005.08.003.pdf,252890,Control,36,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,60.1,44.6,-,Netherlands,0,1,1,148,26.10,PP,0,1,6,months,8.8
Hill 1993.pdf,321117,Behavioural only,713,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.4,53,27.8,-,0,1,1,22,52.20,PP,0,1,,,31
Hill 1993.pdf,321117,Exercise only,714,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.4,53,27.8,-,0,1,1,20,52.20,PP,0,1,,,10
Hill 1993.pdf,321117,Behavioural and exercise,711,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59.4,53,27.8,-,0,1,1,18,52.20,PP,0,1,,,27
Hill 1993.pdf,321117,Behavioural and nicotine gum,712,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,1,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59.4,53,27.8,-,0,1,1,22,52.20,PP,0,1,,,36
Ho 2018.pdf,437515,CDTQ Group,2322,0,1,0,0,0,0,0,1,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,-,14,-,Hong Kong,0,0,0,50,52.20,PP,0,1,,,4
Ho 2018.pdf,437515,QI group,2323,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,-,16,-,Hong Kong,0,0,0,50,52.20,PP,0,1,,,12
Hofmeyr 2019.pdf,437453,Control Group,2190,1,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22.09,99.239,9.89,-,0,0,0,47,26.10,PP,0,1,,,6
Hofmeyr 2019.pdf,437453,Treatment Group,2189,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21.1,99.2,9.82,-,0,0,0,40,26.10,PP,0,1,,,10
Hollands 2012 primary paper.pdf,263149,DNA arm,245,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,58,-,United Kingdom,0,0,0,209,26.10,PP,0,1,,,35
Hollands 2012 primary paper.pdf,263149,Non-DNA arm,246,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,61,-,United Kingdom,0,0,0,217,26.10,PP,0,1,,,36
Hollis 1993.pdf,296432,Advice,817,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,1,40.4,61.6,17.8,-,0,0,0,708,52.20,PP,0,1,,,2.3
Hollis 1993.pdf,296432,Nurse-assisted - Group-Referall,815,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,1,0,1,39.5,55.9,18.4,-,0,0,0,675,52.20,PP,0,1,,,4.7
Hollis 1993.pdf,296432,Nurse-assisted - Combination,814,0,1,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,1,0,1,40.4,58.6,18.4,-,0,0,0,633,52.20,PP,0,1,,,4.3
Hollis 1993.pdf,296432,Nurse-assisted - Self-quit,816,0,1,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,1,0,1,40.3,59.8,18.4,-,0,0,0,675,52.20,PP,0,1,,,3.4
Hollis 2005.pdf,319584,Dietary intervention,639,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,59.6,-,United States,0,0,0,589,8.70,PP,0,1,,,68.6
Hollis 2005.pdf,319584,Tobacco intervention,638,0,0,0,1,1,0,0,0,0,0,1,0,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,-,58.9,-,United States,0,0,0,589,8.70,PP,0,1,,,72.8
Hollis TC 2007.pdf,296274,Brief no NRT,494,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,41.1,59.5,21.9,United States,0,0,0,872,52.20,PP,0,1,,,11.7
Hollis TC 2007.pdf,296274,Intensive with Nicotine Replacement Therapy (NRT),489,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,40.5,59,21.6,United States,0,0,0,721,52.20,PP,0,1,,,21.2
Hollis TC 2007.pdf,296274,Moderate no NRT,493,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,41.4,59.2,21.8,United States,0,0,0,718,52.20,PP,0,1,,,13.8
Hollis TC 2007.pdf,296274,Brief with NRT,491,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,41,60.3,21.8,United States,0,0,0,868,52.20,PP,0,1,,,17.1
Hollis TC 2007.pdf,296274,Intensive no NRT,492,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,40.8,62.2,21.5,United States,0,1,1,720,52.20,PP,0,1,,,14.3
Hollis TC 2007.pdf,296274,Moderate with NRT,490,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,41.4,59.2,22,United States,0,0,0,715,52.20,PP,0,1,,,20.1
Horn 2007.pdf,319585,Motivational Tobacco Intervention (MTI),640,0,0,0,1,0,1,1,0,0,0,1,1,1,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,17.7,58.5,30,-,0,0,0,41,26.10,NCS,0,0,,,2.5
Horn 2007.pdf,319585,Brief Advice (BA),641,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,18,55.9,30,-,0,0,0,34,26.10,NCS,0,0,,,2.9
Horn 2011.pdf,319586,Brief Intervention (BI),644,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.88,-,-,-,0,0,0,63,13.05,PP,0,1,,,12.7
Horn 2011.pdf,319586,Not on Tobacco (N-O-T),643,0,1,0,0,1,0,0,0,0,0,1,0,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.15,-,10,-,0,0,0,90,13.05,PP,0,1,,,20
Horn 2011.pdf,319586,Not on Tobacco plus physical activity (N-O-T+FIT),642,0,1,0,0,1,0,0,0,0,0,1,0,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,-,-,-,0,0,0,80,13.05,PP,0,1,,,33.75
Hoving 2010.pdf,296433,Experimental,818,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,53,22,Dutch,0,0,0,-,52.20,C,1,0,,,2
Hoving 2010.pdf,296433,Control,819,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,54,21,Dutch,0,0,0,-,52.20,C,1,0,,,2
Hughes 2018.pdf,423137,Discontinue patch,2048,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,45,60,19,-,0,0,1,345,26.10,PP,0,1,,,55
Hughes 2018.pdf,423137,Continue patch,2047,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,45,53,19,-,0,0,1,356,26.10,PP,0,1,,,49
Hughes-2010.pdf,263150,Gradual cessation,247,0,1,0,0,0,1,1,1,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,48,54,23,-,0,0,1,297,26.10,C,1,0,,,4
Hughes-2010.pdf,263150,Abrupt cessation,248,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,48,55,23,-,0,0,1,299,26.10,C,1,0,,,7
Hughes-2010.pdf,263150,Minimal treatment,249,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,47,53,24,-,0,0,1,150,26.10,C,1,0,,,5
Humerfelt 1998.pdf,263151,Intervention group,250,0,0,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,37,-,15.9,Norway,0,1,1,1300,52.20,PP,0,1,,,11.1
Humerfelt 1998.pdf,263151,Control,252,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,-,15.8,Norway,0,1,1,1310,52.20,PP,0,1,,,7.4
Humfleet 2013(c) primary paper.pdf,263152,Computer-based intervention,254,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,45,15.1,19.8,-,1,0,0,209,52.00,PP,0,1,,,25.58
Humfleet 2013(c) primary paper.pdf,263152,Individual counseling,253,0,1,1,0,0,1,1,0,1,0,1,1,0,1,0,1,1,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,45,15.1,19.8,-,1,0,0,209,52.00,PP,0,1,,,20.41
Humfleet 2013(c) primary paper.pdf,263152,Self help plus NRT,255,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,45,15.1,19.8,-,1,0,0,209,52.00,PP,0,1,,,19.72
Hurt 2018.pdf,437516,Varenicline,2281,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,40.2,37,19.1,United States,0,1,1,16,24.00,PP,0,1,,,31.3
Hurt 2018.pdf,437516,Placebo,2282,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,38.8,35,21.6,United States,0,1,1,17,24.00,PP,0,1,,,0
Idrisov 2013.pdf,319587,Program,645,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.7,47.5,6.5,Russia,0,0,0,60,26.10,PP,0,1,,,7.5
Idrisov 2013.pdf,319587,Control,646,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.7,47.5,6.5,Russia,0,0,0,70,26.10,PP,0,1,,,0.1
Ingrand 2018.pdf,437518,Simvastasin group,2324,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44.3,47,22.4,France,1,0,0,58,12.00,C,1,0,,,14
Ingrand 2018.pdf,437518,Placebo group,2325,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42.6,35,21.5,France,1,0,0,60,12.00,C,1,0,,,15
Jang 2019.pdf,437454,Intervention,2193,0,1,0,0,0,0,0,0,0,0,1,1,1,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,37.9,-,16.7,Republic of Korea,0,0,0,20,4.35,C,1,0,,,60
Jang 2019.pdf,437454,Control,2194,1,1,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,32.9,4.8,12.9,Republic of Korea,0,0,0,21,4.35,C,1,0,,,52.4
Jason 1987.pdf,321120,No group support (NG),716,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,192,52.20,C,1,0,,,2
Jason 1987.pdf,321120,Group support (G),715,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,233,52.20,C,1,0,,,6
Jason1995 (true primary paper).pdf,263154,Self-help,258,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.4,71,22,United States,0,0,0,280,52.20,PP,0,1,,,7
Jason1995 (true primary paper).pdf,263154,Group,256,0,1,0,0,0,0,1,1,0,1,1,1,0,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38.3,59,20.7,United States,0,0,0,280,52.20,PP,0,1,,,20
Jason1995 (true primary paper).pdf,263154,Incentive,257,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.8,58,21.3,United States,0,0,0,280,52.20,PP,0,1,,,10
Jiang 2007.pdf,296356,Control,428,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,China,0,0,0,84,26.10,PP,0,1,,,39
Jiang 2007.pdf,296356,Intervention,427,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,-,-,-,China,0,0,0,83,26.10,PP,0,1,,,51
Joffe 2009.pdf,319588,Not-on-Tobacco (NOT) intervention,649,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,52,-,United States,0,0,0,92,52.20,PP,0,1,,,7
Joffe 2009.pdf,319588,Kicking butts control,648,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15.6,48,-,United States,0,0,0,89,52.20,PP,0,1,,,12
Joffe 2009.pdf,319588,Not-on-Tobacco control,650,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15.9,45,-,United States,0,0,0,102,52.20,PP,0,1,,,6
Joffe 2009.pdf,319588,Kickin butts intervention,647,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.9,61,-,United States,0,0,0,104,52.20,PP,0,1,,,9
Joyce 2008.pdf,296276,Telephone quitline,497,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,65,57.9,-,United States,0,0,0,1690,52.20,PP,0,1,,,19.3
Joyce 2008.pdf,296276,Provider counseling + pharmacotherapy,498,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,0,1,1,0,0,1,65,61.5,-,United States,0,0,0,2605,52.20,PP,0,1,,,15.8
Joyce 2008.pdf,296276,Provider counseling,499,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,65,57.6,-,United States,0,0,0,829,52.20,PP,0,1,,,14.1
Joyce 2008.pdf,296276,Usual care,500,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,65,60.7,-,United States,0,0,0,2230,52.20,PP,0,1,,,10.2
Kahler 2008 (c) primary paper.pdf,263157,Standard smoking cessation integrating brief alcohol intervention (ST-BI),259,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,41.5,45,21.3,-,0,0,0,117,26.00,PP,0,1,,,13.7
Kahler 2008 (c) primary paper.pdf,263157,Standard smoking cessation (ST),260,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,41.5,45,21.3,-,0,0,0,119,26.00,PP,0,1,,,12.6
Kahler 2015.pdf,423115,Standard Treatment (ST),2106,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,44.5,45.2,18.7,-,0,0,0,31,26.00,PP,0,1,,,6.5
Kahler 2015.pdf,423115,Positive Psychotherapy for Smoking Cessation (PPT-S),2105,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,47.4,54.3,18.8,-,0,0,0,35,26.00,PP,0,1,,,17.1
Katz 2004.pdf,296277,Intervention,501,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,42.8,55,-,-,0,1,1,-,26.10,PP,0,1,,,11
Katz 2004.pdf,296277,Control,502,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,39.9,56,-,-,0,1,1,-,26.10,PP,0,1,,,4
Kelly 2006.pdf,319589,Motivational Interviewing (MI),651,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,15,34,52,Australia,0,0,0,30,26.10,PP,0,1,,,23
Kelly 2006.pdf,319589,Standard care,652,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,15.1,34,49,Australia,0,0,0,26,26.10,PP,0,1,,,12
Killen 2004.pdf,319590,Nicotine patch (NP) + buproprion,653,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,17.32,31,15.12,-,0,1,1,64,26.00,PP,0,1,,,16
Killen 2004.pdf,319590,Nicotine patch (NP) + placebo,654,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,17.32,31,15.65,-,0,1,1,70,26.00,PP,0,1,,,21
Kim 2005.pdf,296357,Control group,430,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,53.1,9.5,-,-,0,0,0,201,21.75,C,1,0,,,9
Kim 2005.pdf,296357,Intervention group,429,0,1,0,0,0,1,0,0,0,0,1,1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,51.6,5.5,-,-,0,0,0,200,21.75,C,1,0,,,14
Kim 2015.pdf,423116,Experimental condition,2107,0,1,0,0,0,1,0,0,0,0,1,1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,multinational,0,0,0,-,52.20,C,1,0,,,38.2
Kim 2015.pdf,423116,Control condition,2108,1,1,0,0,0,1,0,0,0,0,1,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,multinational,0,0,0,-,52.20,C,1,0,,,11.1
Kim 2018.pdf,436360,Video-Call Intervention,2657,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,49.71,-,12.38,-,0,0,0,21,26.10,C,1,0,,,38.1
Kim 2018.pdf,436360,Voice-Call Intervention,2658,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,52.52,-,16.07,-,0,0,0,21,26.10,C,1,0,,,4.8
Kim 2019.pdf,437455,Control group,2208,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,55.3,-,-,-,1,0,0,33,24.00,PP,0,1,,,30.3
Kim 2019.pdf,437455,Aversive advice group,2207,0,1,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,56.6,6.1,-,-,1,0,0,33,24.00,PP,0,1,,,66.7
Krupski 2015.pdf,423139,Patch only (mono-therapy),2052,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,46.9,-,-,0,0,1,1561,30.45,PP,0,1,,,7.4
Krupski 2015.pdf,423139,Patch and Lozenge (combo-therapy),2051,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,47.2,-,-,0,0,1,1557,30.45,PP,0,1,,,8.7
LaChance 2015.pdf,423117,BCT-S,2109,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,1,0,42.2,45.5,17.9,-,0,0,0,26,26.10,PP,0,1,6,months,45
LaChance 2015.pdf,423117,ST,2110,1,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,1,0,43.2,54.5,18.4,-,0,0,0,23,26.10,PP,0,1,6,months,55
Lacasse-2007.pdf,263161,Usual care,266,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,32,22.8,-,0,0,0,86,4.35,PP,0,1,,,34.7
Lacasse-2007.pdf,263161,Smoking cessation intervention,265,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,0,52,36,20.4,-,0,0,0,85,4.35,PP,0,1,,,32.6
Lancaster 1999.pdf,263162,Extended counselling group,267,0,1,0,0,0,1,1,0,0,0,1,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,43,55.4,17,-,0,0,0,249,52.20,C,1,0,,,2.8
Lancaster 1999.pdf,263162,Brief intervention group,268,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,44,48.4,17,-,0,0,0,248,52.20,C,1,0,,,4
Lando (1997).pdf,263163,Orientation session only,271,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,41.3,46.6,27.6,-,0,1,1,174,26.10,C,1,0,,,15
Lando (1997).pdf,263163,Orientation + Help Line + Telephone Outreach,269,0,1,0,0,0,1,1,0,0,0,1,1,0,0,1,1,0,1,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,41.6,60.5,27.4,-,0,1,1,162,26.10,C,1,0,,,17
Lando (1997).pdf,263163,Orientation + Help Line,270,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1,0,1,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,42.9,61.3,28.5,-,0,1,1,173,26.10,C,1,0,,,15
Lando 1988.pdf,296440,Comparison,825,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,41.5,-,31,-,0,1,1,-,52.20,PP,0,1,,,2
Lando 1988.pdf,296440,Experimental Self-help,824,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,41.5,-,31,-,0,1,1,-,52.20,PP,0,1,,,19
Lando 1991.pdf,296441,Quit and win,826,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,-,20,United States,0,0,0,200,30.45,PP,0,1,,,8.9
Lando 1991.pdf,296441,Control,828,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,-,20,United States,0,0,0,170,30.45,PP,0,1,,,10.8
Lando 1991.pdf,296441,Quit for good,827,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,-,20,United States,0,0,0,200,30.45,PP,0,1,,,10.2
Lando 1992.pdf,296278,Intervention,503,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,United States,0,0,0,1453,26.10,PP,0,1,,,5.48
Lando 1992.pdf,296278,Control,504,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,United States,0,0,0,1453,26.10,PP,0,1,,,2.55
Lasser 2017.pdf,423073,Intervention,1992,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49.9,57,15.1,United States,0,0,1,177,52.20,PP,0,1,,,11.9
Lasser 2017.pdf,423073,Control,1993,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,50.1,51,14.9,United States,0,0,1,175,52.20,PP,0,1,,,2.3
Leavens 2018.pdf,437521,Assessment only control,2329,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.75,25.5,1,US,0,0,0,55,13.05,C,1,0,,,45
Leavens 2018.pdf,437521,Intervention,2328,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20.58,22.6,1,US,0,0,0,53,13.05,C,1,0,,,45
Ledgerwood 2014.pdf,263164,Early-treatment enhanced prize reinforcement (ECM),272,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.5,61.1,16.8,-,0,0,0,36,26.10,PP,0,1,,,2.8
Ledgerwood 2014.pdf,263164,Standard care (SC),274,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,58.8,19.3,-,0,0,0,17,26.10,PP,0,1,,,5.9
Ledgerwood 2014.pdf,263164,Traditional prize CM (TCM),273,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.8,64.3,14.7,-,0,0,0,28,26.10,PP,0,1,,,10.7
Lee 2015.pdf,423238,best practice (BP),2120,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,-,7.6,United States,1,0,0,137,21.75,PP,0,1,,,15.4
Lee 2015.pdf,423238,cognitive-behavioral counseling (CBC),2119,0,1,0,0,0,0,1,1,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,27,-,7.6,United States,1,0,0,140,21.75,PP,0,1,,,30.5
Lee 2018.pdf,437522,Control Group (NRT),2265,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,53,10,10.8,Mexico,1,0,0,10,8.00,PP,0,1,,,0
Lee 2018.pdf,437522,Intervention Group (END),2264,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,54,10,15.3,Mexico,1,0,0,20,8.00,PP,0,1,,,15
Lee 2019.pdf,437456,Group 1 (auricular acupressure + counseling),2204,0,1,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,29.28,5.6,14.5,South Korea,0,0,0,18,4.35,C,1,0,,,22
Lee 2019.pdf,437456,Control (self-help smoking cessation),2206,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,28,-,15.72,South Korea,0,0,0,18,4.35,C,1,0,,,5.6
Lee 2019.pdf,437456,Group 2 (placebo acupressure + counseling),2205,0,1,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,29.42,15.8,14.05,South Korea,0,0,0,19,4.35,C,1,0,,,5.3
Leischow 2004.pdf,263165,Over the counter (OTC),276,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,47.05,51,25.8,-,0,1,1,260,52.00,C,1,0,,,0.77
Leischow 2004.pdf,263165,Healthcare provider (HCP),275,0,1,0,0,0,1,1,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,49.39,51,25.8,-,0,1,1,260,52.00,C,1,0,,,3.08
Lepore 2018.pdf,437527,AAR + counseling,2270,0,1,0,0,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,32.7,85.9,12.2,United States,0,0,0,163,52.20,PP,0,1,,,15.2
Lepore 2018.pdf,437527,ARR + control,2271,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,33.9,81.1,10.7,United States,0,0,0,164,52.20,PP,0,1,,,6.7
Levine 2010 (c) primary paper.pdf,263167,Standard cessation counseling (STANDARD) + bupropion (B),1025,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,41,-,20.1,-,0,1,1,89,52.20,C,1,0,,,19
Levine 2010 (c) primary paper.pdf,263167,CBT for smoking-related weight concerns (CONCERNS) + bupropion (B),277,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,42.1,-,20.8,-,0,1,1,106,52.20,C,1,0,,,24
Levine 2010 (c) primary paper.pdf,263167,Standard cessation counseling (STANDARD) + placebo (P),1026,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,42.3,-,21.6,-,0,1,1,67,52.20,C,1,0,,,7
Levine 2010 (c) primary paper.pdf,263167,CBT for smoking-related weight concerns (CONCERNS) + placebo (P),278,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,42.6,-,20.4,-,0,1,1,87,52.20,C,1,0,,,8
Levine 2016.pdf,423089,Time and attention–controlled comparison (SUPPORT),1933,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,-,0,0,0,150,52.00,C,1,0,,,26.7
Levine 2016.pdf,423089,Strategies to Avoid Returning to Smoking (STARTS),1932,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,-,0,0,0,150,52.00,C,1,0,,,21.3
Li 2018.pdf,437528,Control group,2273,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,59,15,12,-,0,0,0,260,26.10,PP,0,1,,,3.8
Li 2018.pdf,437528,Intervention group,2272,0,1,0,0,1,0,1,1,0,0,0,1,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,59,12.7,13,-,0,0,0,268,26.10,PP,0,1,,,5.2
Liao 2018.pdf,436362,High-frequency messaging (HFM),2647,0,1,0,0,0,1,1,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,38.1,4.9,20.3,China,0,0,0,674,24.00,C,1,0,,,6.5
Liao 2018.pdf,436362,Control,2649,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,38.7,5.8,20,China,0,0,0,411,24.00,C,1,0,,,1.9
Liao 2018.pdf,436362,Low-frequency messaging (LFM),2648,0,1,0,0,0,1,1,0,0,0,1,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,37.2,6,19.8,China,0,0,0,284,24.00,C,1,0,,,6
Lichtenstein 2008.pdf,296284,Treatment by video,506,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,18.74,-,0,0,0,676,52.20,PP,0,1,,,4.2
Lichtenstein 2008.pdf,296284,Treatment by phone,505,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,18.76,-,0,0,0,677,52.20,PP,0,1,,,5.1
Lipkus 1999.pdf,296285,Health care provider prompting intervention with tailored communications,508,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,54,-,-,0,0,0,55,69.60,PP,0,1,,,32.7
Lipkus 1999.pdf,296285,Health care provider promoting intervention alone,509,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,54,-,-,0,0,0,53,69.60,PP,0,1,,,13.2
Lipkus 1999.pdf,296285,Health care provider prompting intervention with tailored print communications and tailored telephone counseling,507,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,54,-,-,0,0,0,52,69.60,PP,0,1,,,19.2
Lipkus 2004.pdf,296286,Self-help only,511,0,1,0,0,0,0,1,0,0,1,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,-,49,10,-,0,0,0,193,17.40,C,1,0,,,7
Lipkus 2004.pdf,296286,Counseling,510,0,1,0,1,0,1,1,0,0,1,1,1,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,-,53,10,-,0,0,0,209,17.40,C,1,0,,,9
Lou 2013 DONE IN PILOT.pdf,263170,Behavioural intervention,279,0,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,61.6,-,-,China,1,0,0,1814,208.80,C,1,0,,,44.3
Lou 2013 DONE IN PILOT.pdf,263170,Control,280,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,61.5,-,-,China,1,0,0,1748,208.80,C,1,0,,,5.1
Louwagie 2014.pdf,263171,Control,282,1,1,0,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,42.3,11.8,9.8,South Africa,0,0,1,204,26.10,C,1,0,,,9.3
Louwagie 2014.pdf,263171,Motivational interviewing (MI),281,0,1,0,1,0,0,0,0,0,0,0,0,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,40.3,8.3,10,South Africa,0,0,1,205,26.10,C,1,0,,,21.5
Luo 2018.pdf,437529,Routine 5Rs (control),2284,1,1,0,0,0,0,1,0,0,0,1,1,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,58.6,6.90000000000001,21.4,China,0,0,0,160,24.00,PP,0,1,,,15
Luo 2018.pdf,437529,Intensive personalized ‘5As+5Rs’ intervention (IPANR),2283,0,1,0,0,0,0,1,1,0,0,1,1,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,57.4,4.40000000000001,21.4,China,0,0,0,160,24.00,PP,0,1,,,23.8
Lyu 2018.pdf,437530,Treatment group,2288,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,54.3,-,72.5,China,0,0,0,11,24.00,PP,0,1,,,0
Lyu 2018.pdf,437530,Placebo group,2289,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,56.2,-,77,China,0,0,0,-,24.00,PP,0,1,,,0
Macleod 2003.pdf,296287,NRT only,513,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40.9,49,24.2,-,0,1,1,442,26.10,C,1,0,,,18.6
Macleod 2003.pdf,296287,NRT + telephone counseling,512,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,42.6,54,24,-,0,1,1,412,26.10,C,1,0,,,26.7
Macpherson 2010.pdf,321129,behavioral activation treatment for smoking (BATS),723,0,1,0,0,0,0,1,1,0,1,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,45,48.6,-,-,0,0,0,35,26.00,PP,0,1,,,14.3
Macpherson 2010.pdf,321129,Standard treatment (ST),724,1,1,0,0,0,0,1,0,0,1,1,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,42.6,48.5,-,-,0,0,0,33,26.00,PP,0,1,,,0
Maddison 2014.pdf,436363,Control,2797,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37.3,54.1,19.83,New Zealand,0,0,1,451,24.00,C,1,0,,,18
Maddison 2014.pdf,436363,Intervention,2796,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37.6,54.3,19.41,New Zealand,0,0,1,455,24.00,C,1,0,,,17
Magnan 2009.pdf,263172,Control - personal sigital assistants for smokers daily hassles,284,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27.03,-,7,-,0,0,0,38,26.10,NCS,0,0,,,6.3
Magnan 2009.pdf,263172,Experimental - personal digital assistants for smoking-related support,283,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,-,7,-,0,0,0,81,26.10,NCS,0,0,,,14.3
Marcus 2005 (c) primary paper.pdf,263180,CBT,286,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,43.02,-,20.15,-,0,0,0,108,52.20,PP,0,1,,,8.3
Marcus 2005 (c) primary paper.pdf,263180,Exercise group (CBT+EX),285,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,42.52,-,21.04,-,0,0,0,109,52.20,PP,0,1,,,7.3
Marshall 2016.pdf,423480,Intervention,1968,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,1,0,0,0,63,35.7,-,-,0,0,0,28,52.20,PP,0,1,,,14.3
Marshall 2016.pdf,423480,Control,1969,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,63,37,-,-,0,0,0,27,52.20,PP,0,1,,,18.5
Martin 1997 (c) primary paper.pdf,263183,Standard treatment (ST),289,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,41.5,46,-,-,0,0,0,70,52.20,PP,0,1,,,26
Martin 1997 (c) primary paper.pdf,263183,Behavioral counseling plus exercise (BEX),288,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.5,43,-,-,0,0,0,72,52.20,PP,0,1,,,27
Martin 1997 (c) primary paper.pdf,263183,Behavioral counselling plus nicotine gum (BNIC),287,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,43.6,47,-,-,0,0,0,63,52.20,PP,0,1,,,27
Martinez-Vispo 2019.pdf,437458,SCBSCT-BA,2225,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.24,60.9,18.85,Spain,0,0,0,110,8.00,PP,0,1,8,weeks,64.7
Martinez-Vispo 2019.pdf,437458,SCBSCT,2226,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.61,63.3,19.33,Spain,0,0,0,109,8.00,PP,0,1,8,weeks,45.9
Martinez-Vispo 2019.pdf,437458,Waitlist,2227,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.07,58.9,19.03,Spain,0,0,0,56,13.05,PP,0,1,,,5.4
Masiero 2019.pdf,437459,E-cigarettes,2253,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,62.8,-,19.2,-,0,0,0,170,13.05,C,1,0,,,25.4
Masiero 2019.pdf,437459,Control,2255,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,62.8,-,9.3,-,0,0,0,170,13.05,C,1,0,,,10.34
Masiero 2019.pdf,437459,Placebo,2254,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,62.8,-,19.2,-,0,0,0,170,13.05,C,1,0,,,23.4
Mason_et_al-2012-Addiction.pdf,278612,Standardised report (Control),113,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.8,63.5,18.5,United Kingdom,0,0,0,881,26.10,C,1,0,6,months,9.3
Mason_et_al-2012-Addiction.pdf,278612,Tailored advice report,112,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.8,64.7,17.8,United Kingdom,0,0,0,877,26.10,C,1,0,6,months,9.1
Matthews 2009.pdf,263185,Targeted smoking cessation program (CT),290,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,45.4,90,13,United States,0,0,0,8,26.10,PP,0,1,,,25
Matthews 2009.pdf,263185,Non-targeted smoking cessation program (ST),291,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,45.4,90,13,United States,0,0,0,50,26.10,PP,0,1,,,24
Matthews 2018.pdf,437532,Standard intervention (CTQ),2291,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.4,20.3,13.8,-,0,0,1,-,13.05,PP,0,1,3,months,23.1
Matthews 2018.pdf,437532,Culturally targeted courage to Quit (CTQ-CT),2290,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.6,22.8,12.1,-,0,0,1,-,13.05,PP,0,1,3,months,19.2
May-2006.pdf,263186,Buddy condition,292,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.4,64.1,22.9,United States,1,0,0,237,26.00,C,1,0,,,13
May-2006.pdf,263186,Control,293,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.7,60.7,23.1,United States,1,0,0,326,26.00,C,1,0,,,15
McBride 1999b.pdf,296289,Booklet only,760,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27.8,-,4.8,United States,0,0,0,897,52.20,PP,0,1,,,24
McBride 1999b.pdf,296289,Prepartum group,759,0,1,0,0,0,0,1,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,27.5,-,4.7,United States,0,0,0,294,52.20,PP,0,1,,,23
McBride 1999b.pdf,296289,Post and prepartum group,758,0,1,0,0,0,0,1,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,27.7,-,4.9,United States,0,0,0,306,52.20,PP,0,1,,,25
McBride 2004.pdf,296291,Partner-assisted,514,0,0,0,1,0,0,1,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,24,-,13,-,1,0,0,193,52.20,PP,0,1,,,21
McBride 2004.pdf,296291,Usual care,516,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,24,-,12,-,1,0,0,198,52.20,PP,0,1,,,15
McBride 2004.pdf,296291,Woman only,515,0,0,0,0,0,0,1,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,24,-,13,-,1,0,0,192,52.20,PP,0,1,,,20
McCarthy 2008(c) primary paper.pdf,263189,"Active, No Counselling",295,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,41.03,49.1,22.47,-,0,0,1,463,52.20,C,1,0,,,18.1
McCarthy 2008(c) primary paper.pdf,263189,"Placebo, Counselling",296,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,37.82,52.1,21.98,-,0,0,1,463,52.20,C,1,0,,,12.4
McCarthy 2008(c) primary paper.pdf,263189,"Active, Counselling",294,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,36.76,46,21.87,-,0,0,1,463,52.20,C,1,0,,,20.4
McCarthy 2008(c) primary paper.pdf,263189,"Placebo, No Counselling",297,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,39.42,54,21.37,-,0,0,1,463,52.20,C,1,0,,,14.2
McClure 2005.pdf,296292,Motivationally enhanced phone counselling,517,0,0,0,1,0,1,1,1,0,0,1,1,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,32.7,-,15.1,United States,0,0,0,138,52.20,PP,0,1,,,10.9
McClure 2005.pdf,296292,Usual care control,518,1,0,0,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32.7,-,13.5,United States,0,0,0,137,52.20,PP,0,1,,,10.2
McClure 2011.pdf,296293,Usual care,520,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,45.4,63,11.1,-,0,0,0,23,26.10,PP,0,1,,,20
McClure 2011.pdf,296293,phone-based Step Up counseling plus usual care,519,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.5,72,10,-,0,0,0,23,26.10,PP,0,1,,,11
McClure 2018.pdf,437533,Control,2299,1,0,0,0,0,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.5,62.1,19.1,United States,0,0,0,360,26.10,PP,0,1,,,30.3
McClure 2018.pdf,437533,Experimental (OH4L),2298,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.1,61.5,19.3,United States,0,0,0,358,26.10,PP,0,1,,,33.8
McClure_B_2018.pdf,437534,CBT,2305,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50.8,52.7,-,United States,1,0,1,226,52.20,PP,0,1,,,12.4
McClure_B_2018.pdf,437534,ACT,2304,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,51.8,52.7,-,United States,1,0,1,224,52.20,PP,0,1,,,6.3
McDaniel 2015.pdf,423090,TEQ-10,1935,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,44,54.1,17.2,-,0,0,0,602,52.20,PP,0,1,,,60.6
McDaniel 2015.pdf,423090,Standard,1936,1,0,0,0,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.3,54.2,16.8,-,0,0,0,592,52.20,PP,0,1,,,61.2
McDaniel 2015.pdf,423090,TEQ-20,1934,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,43,54.2,16.4,-,0,0,0,591,52.20,PP,0,1,,,54.9
McDowell_1985_A randomized trial of three approaches.pdf,252892,Group Behaviour Modification,40,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,36.3,60,25,-,0,0,0,87,52.20,NCS,0,0,12,months,17.2
McDowell_1985_A randomized trial of three approaches.pdf,252892,Physician Encouragement,42,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,36.3,60,25.2,-,0,0,0,87,52.20,NCS,0,0,12,months,14.9
McDowell_1985_A randomized trial of three approaches.pdf,252892,Group Health Education,41,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,36.3,60,26.2,-,0,0,0,84,52.20,NCS,0,0,12,months,16.7
McDowell_1985_A randomized trial of three approaches.pdf,252892,Control,43,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,36.3,60,23.4,-,0,0,0,78,52.20,NCS,0,0,12,months,14.1
McFall 1993.pdf,296294,Maintenance,521,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,-,70,-,-,0,0,0,1147,104.40,PP,0,1,,,20
McFall 1993.pdf,296294,Control,522,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,-,69,-,-,0,0,0,598,104.40,PP,0,1,,,24
McFall 2005.pdf,263192,Integrated Care,298,0,1,0,0,0,1,1,0,0,0,0,0,1,1,1,1,1,0,1,0,0,0,1,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,52.9,12,25.2,-,0,0,0,33,39.15,PP,0,1,,,12
McFall 2005.pdf,263192,Standard Care,299,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,52.3,3,29.3,-,0,0,0,33,39.15,PP,0,1,,,3
McFall 2010 (c) primary paper.pdf,263193,Integrated care (IC),300,0,1,0,0,0,1,1,0,0,0,1,1,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,54.4,5.90000000000001,30,US,0,0,0,472,78.30,C,1,0,,,8.9
McFall 2010 (c) primary paper.pdf,263193,Control care (SCC),301,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.7,6.8,30,US,0,0,0,471,78.30,C,1,0,,,4.5
Mercie 2018.pdf,437537,Varenicline group,2605,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,47,19,19,France,0,1,1,102,48.00,C,1,0,,,18
Mercie 2018.pdf,437537,Placebo group,2606,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,44,16,21,France,0,1,1,111,48.00,C,1,0,,,7
Metz NTR 2007.pdf,296295,group smoking cessation program with telephone booster sessions,523,0,0,1,1,0,1,1,0,0,0,1,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,47.2,47.5,14.5,Germany,0,0,0,99,52.20,PP,0,1,,,31.3
Metz NTR 2007.pdf,296295,group smoking cessation program only,524,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,47.1,38.2,16.3,Germany,0,0,0,191,52.20,PP,0,1,,,17.3
Meyer 2012.pdf,296453,Combination,829,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,41.3,47.3,-,Germany,0,0,0,748,52.20,C,1,0,,,12.4
Meyer 2012.pdf,296453,Brief advice,831,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,43.2,47,-,Germany,0,0,0,421,52.20,C,1,0,,,7.9
Meyer 2012.pdf,296453,Tailored letters,830,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,40,-,Germany,0,0,0,1121,52.20,C,1,0,,,8.5
Meyer_2008_Proactive interventions for smoking cessation in_10.1111j.1360-0443.2007.02031.x.pdf,252893,Tailored Letters,44,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33.8,50.4,16.4,Germany,0,0,0,488,104.40,C,1,0,24,months,10.2
Meyer_2008_Proactive interventions for smoking cessation in_10.1111j.1360-0443.2007.02031.x.pdf,252893,Assessment only,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34.8,49.3,16.2,Germany,0,0,0,609,104.40,C,1,0,24,months,6.7
Meyer_2008_Proactive interventions for smoking cessation in_10.1111j.1360-0443.2007.02031.x.pdf,252893,Brief Advice,45,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,33.1,44.5,16.9,Germany,0,0,0,402,104.40,C,1,0,24,months,9.7
Miguez 2002.pdf,296296,Telephone,525,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.7,38,27.3,Spain,0,0,0,100,52.20,C,1,0,,,27
Miguez 2002.pdf,296296,Self-help,526,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35.1,38,28,Spain,0,0,0,100,52.20,C,1,0,,,14
Miguez NTR 2008.pdf,296297,Telephone,527,0,0,0,0,0,0,1,0,0,1,1,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,36.8,45.8,27.7,Spain,0,0,0,118,52.20,C,1,0,,,21.2
Miguez NTR 2008.pdf,296297,Self-help,528,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.4,45.5,26.5,Spain,0,0,0,110,52.20,C,1,0,,,9.1
Miller 1997 (c) primary paper.pdf,263197,Intensive intervention,302,0,1,0,1,0,0,1,0,0,0,1,1,1,0,1,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,1,0,0,-,-,-,United States,0,0,0,540,52.20,PP,0,1,,,27
Miller 1997 (c) primary paper.pdf,263197,Usual care,304,1,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,-,United States,0,0,0,942,52.20,PP,0,1,,,20
Miller 1997 (c) primary paper.pdf,263197,Minimal intervention,303,0,1,0,1,0,0,1,0,0,0,1,1,1,0,1,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,1,0,0,-,-,-,United States,0,0,0,460,52.20,PP,0,1,,,22
Mohiuddin-2007.pdf,263200,Usual care,306,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,55.5,44,22,-,0,0,0,100,104.40,C,1,0,,,9
Mohiuddin-2007.pdf,263200,Intervention,305,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,54,31,26,-,0,0,0,109,104.40,C,1,0,,,39
Morgan_1996_Reaching midlife and older smokers tailored.pdf,252894,Physician-delivered brief advice (Immediate Intervention),13,0,0,0,0,1,1,1,0,1,0,1,0,0,1,0,1,0,0,0,1,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,60.9,54.5,19,-,0,0,0,279,26.10,PP,0,1,6,months,17.8
Morgan_1996_Reaching midlife and older smokers tailored.pdf,252894,Control (Delayed),48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,59.5,57.6,20.9,-,0,0,0,380,26.10,PP,0,1,6,months,1
Morillo-Verdugo 2018.pdf,437539,Intervention group,2296,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,53.6,9.40000000000001,19.4,Spain,0,0,0,21,48.00,NCS,0,0,,,37.9
Morillo-Verdugo 2018.pdf,437539,Control group,2297,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,53.6,9.40000000000001,17.6,Spain,0,0,0,18,48.00,NCS,0,0,,,12.5
Mueller 2012.pdf,263202,Experimental Group (EG),307,0,1,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,44,30.2,25.5,Switzerland,0,0,0,25,26.10,PP,0,1,,,0
Mueller 2012.pdf,263202,Control Group (CG),308,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,44,28,30.5,Switzerland,0,0,0,33,26.10,PP,0,1,,,6
Mundt 2019.pdf,437461,Control group,2197,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.9,60.6,17.4,-,0,0,0,952,26.10,PP,0,1,,,13.8
Mundt 2019.pdf,437461,Intervention group,2196,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,60,17,-,0,0,0,948,26.10,PP,0,1,,,21.6
Muramoto 2007.pdf,319593,Placebo,659,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,-,41.7,-,-,0,1,1,103,6.00,PP,0,1,,,6
Muramoto 2007.pdf,319593,150mg/d sustained release (SR) buproprion (150mg AM),658,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,-,53.3,-,-,0,1,1,105,6.00,PP,0,1,,,11
Muramoto 2007.pdf,319593,300mg/d sustained release (SR) buproprion (150mg AM 150mg PM),657,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,-,42.3,-,-,0,1,1,104,6.00,PP,0,1,,,14
Murray 2008.pdf,263209,Control,310,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,45,49.2,-,UK,0,0,0,3,26.10,PP,0,1,,,2.5
Murray 2008.pdf,263209,Intervention,309,0,1,0,0,1,0,0,0,0,0,1,0,1,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,1,46.6,48.1,-,UK,1,0,0,3,26.10,PP,0,1,,,3.5
Mussulman 2018.pdf,437541,Warm handoff,2636,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.7,24,16.8,-,1,0,0,11,26.10,NCS,0,0,,,45.5
Mussulman 2018.pdf,437541,Fax,2637,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47.7,24,16.8,-,1,0,0,14,26.10,NCS,0,0,,,14.3
Myles 1996.pdf,263210,Message group,311,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,38,36,20,-,0,0,0,185,26.10,NCS,0,0,,,9.5
Myles 1996.pdf,263210,Control group,312,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,37.1,33,21.3,-,0,0,0,178,26.10,NCS,0,0,,,7.9
Nagle 2005.pdf,263211,Control,314,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,-,66.8,-,Australia,0,0,0,711,52.20,C,1,0,,,13.9
Nagle 2005.pdf,263211,Intervention,313,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,-,60.5,-,Australia,0,0,0,711,52.20,C,1,0,,,11.7
Naughton 2014.pdf,423254,Intervention,1970,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,42.3,53.2,18.4,-,0,0,0,299,4.00,PP,0,1,4,weeks,27.1
Naughton 2014.pdf,423254,Control,1971,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,41.3,52.1,18.2,-,0,0,0,303,4.00,PP,0,1,4,weeks,23.4
Nelson 2019.pdf,437463,Snus + Information,2285,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,41.5,50,18.7,US,0,0,1,218,52.20,C,1,0,,,1.4
Nelson 2019.pdf,437463,Nicotine Lozenge,2287,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41.4,51.6,19.2,US,0,0,1,213,52.20,C,1,0,,,0.9
Nelson 2019.pdf,437463,Snus,2286,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43.4,51.4,19.4,US,0,0,1,218,52.20,C,1,0,,,1.4
Nevid 1997.pdf,263212,Multicomponent Behavioral Group,315,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,43.39,53.8,22.93,-,0,0,0,39,52.20,PP,0,1,,,8
Nevid 1997.pdf,263212,Enhanced Self-help Control Group,316,1,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43.95,44.4,19.78,-,0,0,0,54,52.20,PP,0,1,,,7
Ng 2010 DONE IN PILOT.pdf,263213,Cessation clinic (CC),318,0,0,0,1,1,0,1,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,54.9,-,11.1,Indonesia,0,0,0,38,26.10,PP,0,1,,,30.3
Ng 2010 DONE IN PILOT.pdf,263213,Doctors advise (DA),317,0,0,0,1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,58.2,-,10.6,Indonesia,0,0,0,33,26.10,PP,0,1,,,36.8
Nguyen Thanh 2019.pdf,437464,Control,2295,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,35.6,64,16,-,0,0,0,1236,52.20,PP,0,1,,,20.6
Nguyen Thanh 2019.pdf,437464,Intervention,2294,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,36.2,65.7,16,-,0,0,0,1242,52.20,PP,0,1,,,20.9
Nollen 2007.pdf,296454,Standard care,833,1,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,1,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,1,43.1,65.2,18,United States,0,0,0,250,26.10,PP,0,1,,,14.4
Nollen 2007.pdf,296454,Targeted,832,0,1,0,0,0,1,0,0,0,0,1,1,0,1,0,1,1,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,1,42.8,55.2,17.9,United States,0,0,0,250,26.10,PP,0,1,,,18
Nomura 2019.pdf,437465,Telemedicine,2300,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,1,0,1,0,1,1,0,0,1,55,22,-,Japan,0,0,0,58,24.00,C,1,0,,,74.1
Nomura 2019.pdf,437465,Control,2301,1,1,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,1,0,1,1,0,0,0,0,0,0,0,1,1,0,1,0,1,0,1,1,0,0,1,53,16,-,Japan,1,0,0,57,24.00,C,1,0,,,71.9
Noonan 2018.pdf,437545,Scheduled Gradual Reduction (SGR) Group,2343,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,-,75.05,-,-,0,0,0,20,30.00,PP,0,1,,,15
Noonan 2018.pdf,437545,Control Group,2344,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,-,50,-,-,0,0,0,20,30.00,PP,0,1,,,5.3
O'Cleirigh 2018.pdf,423119,Treatment,2111,0,1,1,0,0,1,1,0,0,0,1,1,0,1,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,1,49.73,11.5,14.38,USA,0,0,1,26,26.10,PP,0,1,6,months,46
O'Cleirigh 2018.pdf,423119,Control,2112,1,1,0,0,0,1,0,0,0,0,0,1,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,51.22,18.5,15.39,USA,0,0,1,27,26.10,PP,0,1,6,months,5
O'Malley 2018.pdf,437546,Placebo,2363,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,42.7,29.8,-,-,0,1,1,67,16.00,C,1,0,,,0
O'Malley 2018.pdf,437546,Varenicline,2362,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,42.7,29.8,-,-,0,1,1,64,16.00,C,1,0,,,13
O'Neill 2000.pdf,319594,Control condition - health focused,661,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.7,-,-,-,0,0,0,-,30.45,C,1,0,,,14
O'Neill 2000.pdf,319594,Experimental condition - smoking focused,660,0,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.7,-,-,-,0,0,0,-,30.45,C,1,0,,,19
OXCHECK 1994.pdf,296367,Intervention,439,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,49,56,-,-,0,0,0,2136,4.35,NCS,0,0,,,4
OXCHECK 1994.pdf,296367,Controls,441,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,49,56,-,-,0,0,0,3988,4.35,NCS,0,0,,,5
Ockene 1991.pdf,296298,Counseling,530,0,0,0,0,0,0,0,1,0,0,1,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,35,59,23,-,0,1,1,-,26.10,PP,0,1,,,11
Ockene 1991.pdf,296298,Counseling plus NCG (nicotine-containing gum),529,0,0,0,0,0,0,0,1,0,0,1,0,1,1,0,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,35,56,23,-,0,1,1,-,26.10,PP,0,1,,,17
Ockene 1991.pdf,296298,Advice only,531,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,35,55,22,-,0,1,1,-,26.10,PP,0,1,,,9.1
Okuyemi 2007.pdf,263215,Comparison,320,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,63.6,16,United States,0,0,0,107,26.10,PP,0,1,,,9.35
Okuyemi 2007.pdf,263215,Treatment,319,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,80.3,19,United States,0,0,0,66,26.10,PP,0,1,,,7.6
Okuyemi 2013 (c) primary paper.pdf,263216,Standard Care,322,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,44.2,23.8,19.4,USA,0,0,0,214,26.00,PP,0,1,,,5.6
Okuyemi 2013 (c) primary paper.pdf,263216,Motivational Interviewing (MI),321,0,1,0,1,0,0,0,0,0,0,1,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,44.5,26.9,19.1,USA,0,0,0,216,26.00,PP,0,1,,,9.3
Orleans 1991.pdf,296299,Self-quitting materials + social support instructions + telephone counseling (MST),532,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,-,26,United States,0,0,0,474,16.00,PP,0,1,,,21.5
Orleans 1991.pdf,296299,Control (C),535,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,-,26,United States,0,0,0,465,16.00,PP,0,1,,,15.2
Orleans 1991.pdf,296299,Self-quitting materials (M),534,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,-,26,United States,0,0,0,467,16.00,PP,0,1,,,13.7
Orleans 1991.pdf,296299,Self-quitting materials + social support instructions (MS),533,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,-,26,United States,0,0,0,471,16.00,PP,0,1,,,12.3
Orleans 1998.pdf,296300,Standard,537,1,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,63.6,-,United States,0,0,0,-,26.10,PP,0,1,,,9.1
Orleans 1998.pdf,296300,Tailored,536,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,63.6,-,United States,0,0,0,-,26.10,PP,0,1,,,10.1
Osinubi 2003.pdf,296301,Control,539,1,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,52.71,3.40000000000001,21.38,-,0,0,0,29,26.10,PP,0,1,,,6.9
Osinubi 2003.pdf,296301,Intervention FREE & CLEAR,538,0,0,0,0,0,1,0,0,0,0,1,1,1,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,0,0,0,51.5,10,22.2,-,0,0,0,30,26.10,PP,0,1,,,16.7
Ossip-Klein 1991.pdf,296302,Manual + hotline,540,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,43.32,63.6,27.96,-,0,0,0,894,78.30,C,1,0,,,13.5
Ossip-Klein 1991.pdf,296302,Manual alone,541,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,43.6,63,27.49,-,0,0,0,919,78.30,C,1,0,,,10.8
Ostroff 2014.pdf,263218,Best Practices (BP),324,0,1,0,0,0,0,1,0,0,0,1,0,1,0,1,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,55.4,57,20.6,-,1,0,0,89,26.10,PP,0,1,,,32
Ostroff 2014.pdf,263218,Best Practices + Scheduled Reduced Smoking (BP+SRS),323,0,1,0,0,0,0,1,0,0,0,1,0,1,0,1,1,0,0,1,1,1,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,56.4,49,18.5,-,1,0,0,95,26.10,PP,0,1,,,32
Owen 1989.pdf,296460,Personalized course,834,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,-,27.6,Australia,0,0,0,82,39.15,NCS,0,0,,,10
Owen 1989.pdf,296460,Control,836,1,1,0,0,0,1,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,-,27.6,Australia,0,0,0,40,39.15,NCS,0,0,,,7
Owen 1989.pdf,296460,Standard course,835,1,1,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42,-,27.6,Australia,0,0,0,86,39.15,NCS,0,0,,,18
Paek 2014.pdf,263219,Conventional counselling,326,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.3,-,20.6,South Korea,0,0,0,165,24.00,PP,0,1,,,17.6
Paek 2014.pdf,263219,Intervention,325,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.6,-,22.5,South Korea,0,0,0,167,24.00,PP,0,1,,,21.6
Page_1986_Smoking cessation in family practice the.pdf,252896,Physician advice plus nicotine chewing gum (NCG),50,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,32.5,68,18.8,-,0,0,0,22,26.10,C,1,0,6,months,12
Page_1986_Smoking cessation in family practice the.pdf,252896,Control,51,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,32.5,68,18.8,-,0,0,0,22,26.10,C,1,0,6,months,8.1
Page_1986_Smoking cessation in family practice the.pdf,252896,Advice only,49,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,32.5,68,18.8,-,0,0,0,22,26.10,C,1,0,6,months,8.9
Parkes 2008 primary.pdf,263220,Intervention,327,0,1,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,52.9,55,16.5,England,0,0,0,280,52.20,NCS,0,0,,,13.6
Parkes 2008 primary.pdf,263220,Control,328,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,53,53,17.4,England,0,0,0,281,52.20,NCS,0,0,,,6.4
Patten 2002.pdf,321132,Behavioural Counselling (BC),726,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,44.2,46.1,28.3,-,0,0,0,26,52.20,PP,0,1,,,39.1
Patten 2002.pdf,321132,Cognitive behavioural therapy (CBT),725,0,1,1,0,0,0,1,0,0,1,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,41.3,48,28.5,-,0,0,0,25,52.20,PP,0,1,,,48
Patten 2009.pdf,263224,Telephone counseling,329,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,37,35,16.6,-,0,0,0,29,26.00,PP,0,1,,,3
Patten 2009.pdf,263224,Control group,330,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,47,16.2,-,0,0,0,30,26.00,PP,0,1,,,7
Patten 2017.pdf,423120,Exercise,2103,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,-,26.10,PP,0,1,6,months,27
Patten 2017.pdf,423120,Health Education,2104,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,-,-,-,-,0,0,0,-,26.10,PP,0,1,6,months,40
Patten 2018.pdf,437549,Biomarker feedback intervention,2345,0,1,0,1,0,1,1,0,0,0,1,1,1,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,26.1,-,4.6,United States,0,0,1,30,delivery,PP,0,1,,,20
Patten 2018.pdf,437549,Contact control,2346,1,1,0,1,0,1,1,0,0,0,1,1,1,1,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,27.8,-,4.9,United States,0,0,1,30,delivery,PP,0,1,,,20
Pbert 2004 (c)primary paper.pdf,263225,Usual Care (UC),332,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25.8,-,18.43,-,1,0,0,-,26.10,PP,0,1,,,15
Pbert 2004 (c)primary paper.pdf,263225,Special Intervention (SI),331,0,1,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,25.65,-,14.89,-,1,0,0,-,26.10,PP,0,1,,,15
Pbert 2011.pdf,319595,information-attention control,663,1,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,16.9,44.7,30,-,0,0,0,582,52.20,PP,0,1,,,3.9
Pbert 2011.pdf,319595,counseling intervention,662,0,1,0,0,0,1,1,0,0,1,1,1,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,16.8,51.2,30,-,0,0,0,486,52.20,PP,0,1,,,5.3
Peiris 2019.pdf,436364,Intervention,2659,0,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,42,76,-,-,0,0,0,25,26.10,C,1,0,,,4.5
Peiris 2019.pdf,436364,Control,2660,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,79,-,-,0,0,0,24,26.10,C,1,0,,,0
Pericot-Valverde 2019.pdf,437466,CBT,2267,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,39.21,63.5,19.4,Spain,0,0,0,52,52.20,C,1,0,,,17
Pericot-Valverde 2019.pdf,437466,CBT + CET,2266,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,39.68,72,18.7,Spain,0,0,0,50,52.20,C,1,0,,,16
Perkins 2001.pdf,263227,CBT,334,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.3,-,20.8,-,0,0,0,72,52.20,C,1,0,,,21
Perkins 2001.pdf,263227,Weight control,333,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.7,-,22.3,-,0,0,0,72,52.20,C,1,0,,,13
Perkins 2001.pdf,263227,Standard,335,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.6,-,22,-,0,0,0,75,52.20,C,1,0,,,9
Peterson 2009 - main paper.pdf,319596,Counselor-initiated Telephone Intervention,664,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,-,47,-,-,0,0,0,1058,4.35,C,1,0,,,21.8
Peterson 2009 - main paper.pdf,319596,Control,665,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,47,-,-,0,0,0,1093,4.35,C,1,0,,,17.7
Pieterse_2001_Effectiveness of a minimal contact smoking_10.1006pmed.2000.0791.pdf,252897,Usual Care,53,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35.6,61.6,-,Netherlands,0,0,0,261,52.20,PP,0,1,12,months,7.3
Pieterse_2001_Effectiveness of a minimal contact smoking_10.1006pmed.2000.0791.pdf,252897,Minimal Contact Smoking Cessation Program,52,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,35.8,58.4,-,Netherlands,0,0,0,269,52.20,PP,0,1,12,months,13.4
Piper 2018.pdf,437551,Abstinence-optimized treatment (A-OT),2609,0,1,0,0,0,0,1,1,0,0,1,1,1,0,0,1,0,0,1,1,0,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,50,56.2,16.5,-,1,0,0,308,26.00,PP,0,1,,,15.9
Piper 2018.pdf,437551,Recommended usual care (R-UC),2610,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,49.4,58.4,17.1,-,1,0,0,315,26.00,PP,0,1,,,6
Pisinger 2005.pdf,321133,High intensity intervention (Group A),727,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,1,0,0,46,49.7,17.7,Denmark,0,1,1,1245,4.35,PP,0,1,,,19.28
Pisinger 2005.pdf,321133,Control (Group C),729,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,49.6,17.4,Denmark,0,1,1,1005,4.35,PP,0,1,,,7.26
Pisinger 2005.pdf,321133,Low intensity intervention (Group B),728,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,49.7,17.7,Denmark,0,1,1,142,4.35,PP,0,1,,,16.2
Pisinger 2009.pdf,321137,referral to group-based SC counselling (Group A),730,0,1,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,47.45,61.2,17.25,Denmark,0,0,0,600,4.35,PP,0,1,,,3.5
Pisinger 2009.pdf,321137,referral to internet-based SC programme (Group B),731,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,49.63,63.2,18.12,Denmark,0,0,0,476,4.35,PP,0,1,,,2.5
Pisinger 2009.pdf,321137,Control,732,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,46.97,63.4,16.25,Denmark,0,0,0,442,4.35,PP,0,1,,,2.7
Point-prevalence abstinence at the 24-week,263139,Modified Usual Care (UC),235,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.1,53.6,-,-,0,0,0,673,52.20,PP,0,1,,,8.8
Point-prevalence abstinence at the 24-week,263139,Advice + Counseling (A+C),233,0,1,0,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,0,47.5,51.9,-,-,0,0,0,666,52.20,PP,0,1,,,9.9
Point-prevalence abstinence at the 24-week,263139,Advice (A),234,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,0,47.9,52.9,-,-,0,0,0,678,52.20,PP,0,1,,,10
Pollak 2014.pdf,423242,Materials alone,2129,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,29,-,-,United States,0,0,0,175,52.20,PP,0,1,,,0.3
Pollak 2014.pdf,423242,Materials + counseling,2128,0,1,0,0,0,1,1,0,0,0,1,1,0,1,0,1,0,0,1,1,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,30,-,-,United States,0,0,0,173,52.20,PP,0,1,,,0.3
Pollak 2016.pdf,423091,Intervention,1937,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,25,-,-,-,0,0,0,188,52.20,PP,0,1,,,35
Pollak 2016.pdf,423091,Control,1938,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,-,-,-,0,0,0,194,52.20,PP,0,1,,,36
Pollak 2018.pdf,437552,Intervention,2617,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,59.64,71,13.29,-,0,0,0,14,8.70,PP,0,1,,,14
Pollak 2018.pdf,437552,Wait-list control,2618,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54.31,62.5,13.63,-,0,0,0,16,8.70,PP,0,1,2,months,6
Prapavessis 2007.pdf,263228,CBT + nicotine patch,337,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,1,1,26,52.20,C,1,0,,,15
Prapavessis 2007.pdf,263228,Exercise,1030,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,1,1,35,52.20,C,1,0,,,9
Prapavessis 2007.pdf,263228,CBT,1031,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,1,1,27,52.20,C,1,0,,,15
Prapavessis 2007.pdf,263228,Exercise + nicotine patch,336,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,1,1,33,52.20,C,1,0,,,27
Prapavessis 2016 (c) primary paper.pdf,263229,Contact Control,341,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,40.36,-,16.41,-,0,0,0,89,52.20,C,1,0,,,20.7
Prapavessis 2016 (c) primary paper.pdf,263229,Exercise Maintenance + Smoking Cessation Maintenance,338,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41.96,-,17.04,-,0,0,0,89,52.20,C,1,0,,,32.8
Prapavessis 2016 (c) primary paper.pdf,263229,Exercise Maintenance + Contact Control,339,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43.47,-,16.71,-,0,0,0,89,52.20,C,1,0,,,19
Prapavessis 2016 (c) primary paper.pdf,263229,Smoking Cessation Maintenance + Contact Control,340,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,43.45,-,16.88,-,0,0,0,89,52.20,C,1,0,,,27.6
Prochaska 2001.pdf,296305,Expert system plus lifesign computer (ES 1 SC),547,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38.9,56,19,-,0,0,0,374,78.30,PP,0,1,,,10.2
Prochaska 2001.pdf,296305,Expert system plus counselors (ES 1 CO),546,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38,56,21.7,-,0,0,0,361,78.30,PP,0,1,,,13
Prochaska 2001.pdf,296305,Expert system (ES),548,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38.5,56,18.9,-,0,0,0,362,78.30,PP,0,1,,,14.4
Prochaska 2001.pdf,296305,Assesment only (AS),549,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.7,56,20.1,-,0,0,0,350,78.30,PP,0,1,,,12.6
Prochaska 2004.pdf,296469,Expert system,843,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,349,104.40,C,1,0,,,15
Prochaska 2004.pdf,296469,Assessment only,844,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,-,0,0,0,362,104.40,C,1,0,,,8
Prochaska 2005.pdf,296470,Assessment only,846,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,-,-,-,0,0,0,437,104.40,PP,0,1,,,18.5
Prochaska 2005.pdf,296470,Intervention,845,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,-,-,-,0,0,0,437,104.40,PP,0,1,,,25.4
Prokhorov 2008 (c) primary paper.pdf,263231,Standard Care (SC),343,1,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22.9,54,12.9,-,0,0,0,168,43.50,PP,0,1,,,10.1
Prokhorov 2008 (c) primary paper.pdf,263231,Look At Your Health (LAYH),342,0,1,0,1,0,0,0,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22.8,63,12,-,0,0,0,158,43.50,PP,0,1,,,16.6
Prue 1983.pdf,296471,Minimal contact (MCBF),847,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,45.25,-,-,-,0,0,0,30,26.10,NCS,0,0,,,27
Prue 1983.pdf,296471,Wait list (WLC),848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.25,-,-,-,0,0,0,10,26.10,NCS,0,0,,,10
Quist-Paulsen 2003.pdf,296368,Intervention group,433,0,1,0,0,0,0,1,1,0,0,1,1,0,1,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,1,57,24,14.3,Norway,0,0,0,100,52.20,NCS,0,0,,,57
Quist-Paulsen 2003.pdf,296368,Control group,434,1,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,1,57,25,15.6,Norway,0,0,0,118,52.20,NCS,0,0,,,37
Rabius TC 2007.pdf,296307,50 minutes telephone counseling,557,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,1,30.45,PP,0,1,,,10
Rabius TC 2007.pdf,296307,210 minutes telephone counseling,553,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,7,30.45,PP,0,1,,,12.7
Rabius TC 2007.pdf,296307,80 minutes telephone counseling,556,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,2,30.45,PP,0,1,,,14.1
Rabius TC 2007.pdf,296307,Self help,558,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,70,-,-,0,0,0,1,30.45,PP,0,1,,,7.6
Rabius TC 2007.pdf,296307,135 minutes telephone counseling,554,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,8,30.45,PP,0,1,,,10.8
Rabius TC 2007.pdf,296307,105 minutes telephone counseling,555,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,8,30.45,PP,0,1,,,8.5
Rabius TC 2007.pdf,296307,240 minutes telephone counseling,552,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,70,-,-,0,0,0,8,30.45,PP,0,1,,,11.7
Ratner 2004.pdf,263234,Treatment,347,0,1,0,0,0,1,1,0,0,0,1,1,1,0,1,1,0,0,1,1,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,50.7,52.5,11.8,Canada,0,0,0,117,52.20,NCS,0,0,,,18.8
Ratner 2004.pdf,263234,Control,348,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,48.8,51.3,12.6,Canada,0,0,0,120,52.20,NCS,0,0,,,19.2
Redding 2015.pdf,319599,Usual care,669,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,16.4,-,-,United States,0,0,0,43,78.30,NCS,0,0,,,23.3
Redding 2015.pdf,319599,Transtheoretical model (TTM),668,0,0,0,1,0,0,1,0,1,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,16.4,-,-,United States,0,0,0,45,78.30,NCS,0,0,,,28.9
Reid 1999.pdf,296308,Usual care,560,1,0,0,0,0,1,0,0,0,0,0,1,1,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,0,37.5,47.7,6.9,United States,0,0,1,199,52.00,PP,0,1,,,24.1
Reid 1999.pdf,296308,Telephone counseling,559,0,0,0,0,0,1,0,0,0,0,1,1,1,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,38.4,47.2,24.2,United States,0,0,1,197,52.00,PP,0,1,,,23.4
Reid 2008 (c) primary paper.pdf,263235,Smoking Cessation (SC),349,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,41.6,49,22.3,-,0,0,0,153,26.00,PP,0,1,,,5.7
Reid 2008 (c) primary paper.pdf,263235,Treatment as Usual (TAU),350,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,41,47,21.6,-,0,0,0,72,26.00,PP,0,1,,,5.2
Reid 2018.pdf,437555,Wait-list Control,2646,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,55,43,20,Canada,0,1,1,114,26.10,PP,0,1,,,2.6
Reid 2018.pdf,437555,OMSC Intervention,2645,0,1,0,0,0,1,1,1,0,0,1,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,1,0,1,54,45,19,Canada,0,1,1,198,26.10,PP,0,1,,,11.1
Reid Patient Educ Couns 2007.pdf,296309,Interactive voice response (IVR),561,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,54,39,-,United States,1,0,0,50,52.00,PP,0,1,,,46
Reid Patient Educ Couns 2007.pdf,296309,Control,562,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,53.9,26,-,United States,1,0,0,49,52.00,PP,0,1,,,34.7
Reitzel-2011.pdf,263238,Computer-delivered treatment (CDT),351,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,1,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,41.7,45.4,22.3,-,0,0,0,152,52.20,PP,0,1,,,11.2
Reitzel-2011.pdf,263238,Standard treatment (ST),352,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,41.2,51,22.7,-,0,0,0,151,52.20,PP,0,1,,,13.9
Rettig 2018.pdf,423075,Intervention,1997,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,1,0,0,1,1,1,1,1,0,1,0,0,0,0,1,-,42,10,-,0,0,0,19,8.00,PP,0,1,,,74
Rettig 2018.pdf,423075,Control,1998,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,30,7.5,-,0,0,0,11,8.00,PP,0,1,,,30
Richmond_1985_Evaluation of general practitioners use of.pdf,252898,GP Counselling,54,0,1,0,0,0,0,1,0,0,1,1,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,-,-,Australia,0,0,0,100,26.10,NCS,0,0,6,months,33
Richmond_1985_Evaluation of general practitioners use of.pdf,252898,Control,55,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,Australia,0,0,0,-,26.10,NCS,0,0,6,months,3
Rigotti 1994.pdf,296370,Behaviour modification program,442,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,58,23,28,-,0,0,0,44,287.10,C,1,0,5.5,years,44
Rigotti 1994.pdf,296370,Usual care,443,1,1,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59,23,32,-,0,0,0,43,287.10,C,1,0,5.5,years,44
Rigotti 2006 primary paper.pdf,263239,Best practice with telephone counseling,353,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,28.9,-,10.4,-,0,0,0,209,13.05,PP,0,1,,,10
Rigotti 2006 primary paper.pdf,263239,Best practice,354,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,28.1,-,10,-,0,0,0,210,13.05,PP,0,1,,,7.5
Rigotti 2014 primary paper.pdf,263242,Standard care,356,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,53,52,16.7,-,0,0,1,199,26.10,PP,0,1,,,15
Rigotti 2014 primary paper.pdf,263242,Sustained care intervention,355,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,53,52,16.7,-,0,0,1,198,26.10,PP,0,1,,,26
Rimer 1994.pdf,296311,Clear Horizons guide only,564,0,0,0,0,0,1,1,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,61,63,27,United States,0,0,0,511,13.05,PP,0,1,,,7
Rimer 1994.pdf,296311,Clear Horizons guide plus calls,563,0,0,0,0,0,1,1,0,1,0,1,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,61,64,27,United States,0,0,0,537,13.05,PP,0,1,,,10
Rimer 1994.pdf,296311,Control,565,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,62,62,26,United States,0,0,0,505,13.05,PP,0,1,,,6
Risser 1990.pdf,296371,Control group,445,1,1,0,0,0,1,0,0,0,0,1,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,7,24,-,0,0,0,30,4.35,PP,0,1,,,6.7
Risser 1990.pdf,296371,Motivational group,444,0,1,0,0,0,1,0,0,0,0,1,1,1,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,-,2,23,-,0,0,0,27,4.35,PP,0,1,,,20
Robinson 2003.pdf,319600,Control,671,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,33.7,-,-,0,0,0,92,52.20,PP,0,1,,,6
Robinson 2003.pdf,319600,Start to Stop (STS),670,0,1,0,1,0,1,1,0,0,0,1,0,0,1,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,37.9,-,-,0,0,0,169,52.20,PP,0,1,,,6
Rodondi 2012 primary paper.pdf,263244,ultrasonographic screening (US),357,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,51.5,46.4,-,Switzerland,0,0,0,267,52.20,PP,0,1,,,24.9
Rodondi 2012 primary paper.pdf,263244,Control,358,1,1,0,0,0,1,0,0,0,0,1,0,0,0,1,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,50.7,-,-,Switzerland,0,0,0,269,52.20,PP,0,1,,,22.1
Rohsenow 2015.pdf,263247,MI + NCV,360,0,1,0,1,0,0,1,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,34.5,55.4,22.3,-,0,0,0,44,52.20,PP,0,1,,,4.5
Rohsenow 2015.pdf,263247,motivational interviewing (MI) + CV,359,0,1,0,1,0,0,1,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,34.5,55.4,22.3,-,0,0,0,53,52.20,PP,0,1,,,7.5
Rohsenow 2015.pdf,263247,Brief Advice (BA) + CV,361,0,1,0,0,1,1,1,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,34.5,55.4,22.3,-,0,0,0,44,52.20,PP,0,1,,,0
Rohsenow 2015.pdf,263247,Brief Advice + NCV,362,0,1,0,0,1,1,1,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,34.5,55.4,22.3,-,0,0,0,42,52.20,PP,0,1,,,4.8
Rohsenow 2017.pdf,423076,Contingent Vouchers (CV),1999,0,1,0,0,0,1,1,0,0,0,0,1,1,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,37.87,34,19.95,-,0,0,0,172,52.20,PP,0,1,,,3.7
Rohsenow 2017.pdf,423076,Noncontingent Vouchers (NV),2000,0,1,0,0,0,1,1,0,0,0,0,1,1,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,37.28,31,18.99,-,0,0,0,168,52.20,PP,0,1,,,1.8
Romand-2005.pdf,263248,Control group,364,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,54,-,France,0,0,0,109,52.20,C,1,0,,,3
Romand-2005.pdf,263248,Test group,363,0,1,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,-,54,-,France,0,0,0,119,52.20,C,1,0,,,13
Romanowich 2015.pdf,423077,Control,2003,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.6,55,21.9,-,0,0,0,29,26.10,pp,0,1,,,14
Romanowich 2015.pdf,423077,Escalating reinforcement schedule,2001,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.9,42,21.7,-,0,0,0,59,26.10,pp,0,1,,,10
Romanowich 2015.pdf,423077,Fixed reinforcement schedule,2002,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.3,45,24.3,-,0,0,0,58,26.10,pp,0,1,,,12
Ronaldson 2018.pdf,437558,Waiting list,2683,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,53.4,48.6,16.2,England,0,0,0,334,8.70,NCS,0,0,,,6.3
Ronaldson 2018.pdf,437558,Tests now,2682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,53.5,50.6,15.9,England,0,0,0,340,8.70,NCS,0,0,,,5.3
Rose_1978_A randomised controlled trial of the.pdf,252899,Intervention,56,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,52,-,19,-,0,0,0,714,156.60,NCS,0,0,3,years,36
Rose_1978_A randomised controlled trial of the.pdf,252899,Normal Care,57,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,-,18,-,0,0,0,731,156.60,NCS,0,0,3,years,14
Roski 2003.pdf,296312,Control,567,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,-,-,-,-,0,0,0,1065,26.10,PP,0,1,,,19.2
Roski 2003.pdf,296312,Incentive,566,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,-,0,0,0,-,26.10,PP,0,1,,,21.7
Rovina 2009.pdf,321139,buproprion with nonspecific supportive and motivational group therapy (NSGT) (Group B),734,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,45.3,34.3,38.1,United States,0,0,0,35,52.20,C,1,0,,,28.1
Rovina 2009.pdf,321139,bupropion with cognitive behavioral group therapy (CBGT) (Group C),733,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,44.7,50,34.7,United States,0,0,0,40,52.20,C,1,0,,,34.3
Rovina 2009.pdf,321139,Cognitive behavioural group therapy (CBGT) only (Group D),736,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,44.5,52.8,34.2,United States,0,0,0,36,52.20,C,1,0,,,19.4
Rovina 2009.pdf,321139,Buprioprion with physician counseling (Group A),735,0,1,0,0,0,0,1,1,0,0,1,1,0,1,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,44.65,30.5,37.8,United States,0,0,0,94,52.20,C,1,0,,,29.6
Russell_1979_Effect of general practitioners advice against.pdf,252901,Advice by GP (Group 3),59,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,United States,0,0,0,389,52.20,PP,0,1,12,months,16
Russell_1979_Effect of general practitioners advice against.pdf,252901,"Advice, leaflet & follow-up (Group 4)",58,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,-,-,United States,0,0,0,408,52.20,PP,0,1,12,months,19
Russell_1979_Effect of general practitioners advice against.pdf,252901,Questionnaire-only Control (Group 2),60,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,United States,0,0,0,430,52.20,PP,0,1,12,months,14
Russell_1979_Effect of general practitioners advice against.pdf,252901,Control (Group 1),61,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,United States,0,0,0,340,52.20,PP,0,1,12,months,10
Russell_1983_Effect of nicotine chewing gum as.pdf,252903,Advice and Nicorette (Group 3),62,0,1,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,1,40,57,17,Canada,0,0,0,679,52.20,NCS,0,0,1,years,16
Russell_1983_Effect of nicotine chewing gum as.pdf,252903,Advice and booklet (Group 2),63,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,40,57,17,Canada,0,0,0,675,52.20,NCS,0,0,1,years,10
Russell_1983_Effect of nicotine chewing gum as.pdf,252903,No advice control (Group 1),64,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,40,57,17,Canada,0,0,0,584,52.20,NCS,0,0,1,years,13
Sanders 1989.pdf,296372,Controls,755,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,-,0,0,0,642,4.35,C,1,0,,,0.9
Sanders 1989.pdf,296372,Intervention,753,0,1,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,-,-,-,-,0,0,0,-,4.35,C,1,0,,,3.6
Sawicki 1993.pdf,321141,Control group,738,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,38,38,20,Germany,0,1,1,3,26.10,NCS,0,0,,,16
Sawicki 1993.pdf,321141,Intervention group,737,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,37,41,23,Germany,0,1,1,2,26.10,NCS,0,0,,,5
Scheffers-Van Schayck 2019.pdf,437468,Intervention,2330,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.3,53.3,15,Netherlands,0,0,0,45,13.05,PP,0,1,,,53.3
Scheffers-Van Schayck 2019.pdf,437468,Control,2331,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39.1,63.2,16,Netherlands,0,0,0,38,13.05,PP,0,1,,,13.2
Scherphof 2014a.pdf,319601,Nicotine patch,672,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16.56,59.3,-,Netherlands,0,0,0,135,day after fi nishing treatment,C,1,0,na,,14.8
Scherphof 2014a.pdf,319601,Placebo patch,673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16.7,45.9,-,Netherlands,0,0,0,122,day after fi nishing treatment,C,1,0,na,,13.1
Scherphof 2014b.pdf,319602,Nicotine patch,674,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16.7,-,-,-,0,1,1,135,52.20,PP,0,1,,,4.4
Scherphof 2014b.pdf,319602,Placebo patch,675,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16.7,-,-,-,0,1,1,122,52.20,PP,0,1,,,6.6
Schleicher 2012.pdf,321144,Nutrition group,740,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,51,-,-,0,0,0,15,26.10,PP,0,1,,,10.3
Schleicher 2012.pdf,321144,Smoking group,739,0,0,1,0,0,1,1,0,0,1,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,51,-,-,0,0,0,19,26.10,PP,0,1,,,13.8
Schnoll 2015.pdf,423092,Extended Treatment ,2076,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46.9,54.9,17,United States,0,0,1,173,52.00,PP,0,1,52,weeks,26
Schnoll 2015.pdf,423092,Standard Treatment ,2077,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45.9,50,16.9,United States,0,0,1,180,52.00,PP,0,1,52,weeks,21.7
Schnoll 2015.pdf,423092,Maintenance Treatment ,2075,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46.4,47.1,17.4,United States,0,0,1,172,52.00,PP,0,1,52,weeks,20.3
Schnoll 2019.pdf,437469,Extended,2335,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,58,56.2,13.5,-,0,1,1,105,52.00,PP,0,1,,,15.7
Schnoll 2019.pdf,437469,Standard,2336,1,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,60,45.1,13.2,-,0,1,1,102,52.00,PP,0,1,,,10.5
Schnoll_2003_Brief physician initiated quit smoking strategies_10.1200JCO.2003.04.122.pdf,252904,Usual Care,66,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,60.8,-,-,0,0,0,217,52.20,PP,0,1,12,months,13.6
Schnoll_2003_Brief physician initiated quit smoking strategies_10.1200JCO.2003.04.122.pdf,252904,Physician-Based Intervention,65,0,0,0,0,1,1,0,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,70.7,-,-,0,0,0,215,52.20,PP,0,1,12,months,13.3
Schofield 1999.pdf,296474,Control,850,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,-,-,Australia,0,0,0,2465,52.20,PP,0,1,,,13
Schofield 1999.pdf,296474,Intervention,849,0,1,0,0,0,0,1,0,0,0,0,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,-,-,Australia,0,0,0,2465,52.20,PP,0,1,,,12
Schumann 2008.pdf,296476,Intervention,851,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.8,46.7,-,Germany,0,0,0,302,104.40,pp,0,1,,,16
Schumann 2008.pdf,296476,Control,852,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.2,45.6,-,Germany,0,0,0,309,104.40,pp,0,1,,,16.2
Secades Villa 2014.pdf,263249,cognitive behavioural therapy + contingency management (CBT + CM),365,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,44.4,69.8,21.6,Spain,0,0,0,43,26.10,C,1,0,,,39.5
Secades Villa 2014.pdf,263249,Cognitive behavioural therapy (CBT),366,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,46.9,59.2,21.8,Spain,0,0,0,49,26.10,C,1,0,,,26.5
Segnan_1991_A randomized trial of smoking cessation.pdf,252905,Repeated counselling plus nicotine gum,68,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,1,0,0,0,-,36.7,-,n Ita,0,0,0,294,52.20,PP,0,1,12,months,7
Segnan_1991_A randomized trial of smoking cessation.pdf,252905,Minimal intervention,70,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,32,-,n Ita,0,0,0,62,52.20,PP,0,1,12,months,4
Segnan_1991_A randomized trial of smoking cessation.pdf,252905,Repeated counselling plus spirometry,67,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,40,-,n Ita,0,0,0,292,52.20,PP,0,1,12,months,6
Segnan_1991_A randomized trial of smoking cessation.pdf,252905,Repeated counselling,69,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,39.6,-,n Ita,0,0,0,275,52.20,PP,0,1,12,months,5
Seversen_1997_Reducing maternal smoking and relapse long.pdf,252907,Extended,75,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,-,United States,0,0,0,609,52.20,C,1,0,12,months,32.8
Seversen_1997_Reducing maternal smoking and relapse long.pdf,252907,Minimal,76,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,-,United States,0,0,0,417,52.20,C,1,0,12,months,26.1
Sharma 2018.pdf,437559,Counselling alone,2348,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,34.23,-,-,India,1,0,0,397,24.00,NCS,0,0,,,32.4
Sharma 2018.pdf,437559,Nicotine replacement therapy and behaviour change counselling,2347,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,34.9,-,-,India,1,0,0,398,24.00,NCS,0,0,,,47.8
Sherman 2016.pdf,423481,Quitline,1973,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,48,22,12.5,-,0,0,0,814,26.10,PP,0,1,,,2
Sherman 2016.pdf,423481,Intensive counseling,1972,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,49,20,12.3,-,0,0,0,804,26.10,PP,0,1,,,2
Sherman 2018.pdf,437560,Self-help + proactive telephone,2792,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,1,54,6.8,17.6,United States,0,0,0,592,26.10,PP,0,1,,,12.5
Sherman 2018.pdf,437560,Self-help + reactive telephone,2793,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,1,55.1,4.8,20.1,United States,0,0,0,525,26.10,PP,0,1,,,13.5
Sherman 2018.pdf,437560,Counselling + reactive telephone,2791,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,1,54.2,7,18.3,United States,0,0,0,934,26.10,PP,0,1,,,12.9
Sherman 2018.pdf,437560,Counselling + proactive telephone,2790,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,1,53.7,5.1,17.7,United States,0,0,0,1069,26.10,PP,0,1,,,14.7
Sherratt 2018.pdf,437561,Control,2801,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,56.8,-,United Kingdom,0,0,0,146,26.10,PP,0,1,,,35.9
Sherratt 2018.pdf,437561,Intervention,2800,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,62.3,-,United Kingdom,0,0,0,151,26.10,PP,0,1,,,50.4
Shiffman 2018.pdf,437562,NNCCs,2799,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38.4,55,1.9,United States,0,0,1,120,9.00,PP,0,1,,,5
Shiffman 2018.pdf,437562,VLNCCs,2798,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37.4,55,1.9,United States,0,0,1,118,9.00,PP,0,1,,,10.2
Shiffman 2019.pdf,437470,Placebo,2312,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,45.4,54.3,1.9,United States,0,1,1,188,26.10,C,1,0,,,5.3
Shiffman 2019.pdf,437470,Nicotine gum,2311,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,42.2,59.7,1.8,United States,0,1,1,181,26.10,C,1,0,,,7.2
Shishani_B_ 2018.pdf,437564,Contingent,2802,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.7,37,-,-,0,0,0,19,5.00,C,1,0,,,42.1
Shishani_B_ 2018.pdf,437564,Non-contingent,2803,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.3,35,-,-,0,0,0,20,5.00,C,1,0,,,5
Siddiqi 2013 primary paper.pdf,263250,Behavioral support sessions plus 7 wk of bupropion therapy (BSS+),367,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,0,1,38.3,5,-,Pakistan,1,0,0,659,26.10,C,1,0,,,45.4
Siddiqi 2013 primary paper.pdf,263250,Control,369,1,1,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,41.7,3,-,Pakistan,1,0,0,656,26.10,C,1,0,,,8.5
Siddiqi 2013 primary paper.pdf,263250,Behavioral support sessions (BSS),368,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,42.8,6,-,Pakistan,1,0,0,640,26.10,C,1,0,,,41
Simmons 2013.pdf,263257,Group intervention,371,0,1,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20.35,34.5,47.86,-,0,0,0,84,26.10,PP,0,1,,,15.5
Simmons 2013.pdf,263257,Didactic,373,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.64,44,44.76,-,0,0,0,84,26.10,PP,0,1,,,17.9
Simmons 2013.pdf,263257,Web-Smoke,370,0,1,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.42,45.7,46.44,-,0,0,0,81,26.10,PP,0,1,,,22.2
Simmons 2013.pdf,263257,Web-nutrition,372,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.77,52.4,46.63,-,0,0,0,82,26.10,PP,0,1,,,9.8
Simmons 2018.pdf,437565,Standard Repeated Mailings,2805,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.5,66,20.5,-,0,0,0,614,130.50,PP,0,1,,,28.8
Simmons 2018.pdf,437565,Traditional Self-help,2806,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.5,66,20.5,-,0,0,0,638,130.50,PP,0,1,,,23.3
Simmons 2018.pdf,437565,Intensive Repeated Mailings,2804,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47.5,66,20.5,-,0,0,0,622,130.50,PP,0,1,,,33.4
Simmons_2007_Secondary Smoking Prevention in a University_10.10370278-6133.26.3.268.pdf,263045,Exp-Smoke intervention,114,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.2,-,55.4,-,0,0,0,-,4.35,PP,0,1,1,months,9.9
Simmons_2007_Secondary Smoking Prevention in a University_10.10370278-6133.26.3.268.pdf,263045,Exp-Nutrition intervention,115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.2,-,55.4,-,0,0,0,-,4.35,PP,0,1,1,months,1.4
Simmons_2007_Secondary Smoking Prevention in a University_10.10370278-6133.26.3.268.pdf,263045,Standard,116,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.2,-,55.4,-,0,0,0,-,4.35,PP,0,1,1,months,12.5
Simon 2003 DONE IN PILOT.pdf,263259,Intensive counseling + telephone follow-up,374,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,55,2,23,Mexico,0,0,0,102,52.20,PP,0,1,,,29
Simon 2003 DONE IN PILOT.pdf,263259,Minimal contact intervention + transdermal nicotine,375,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,1,54,3,24,Mexico,0,0,0,107,52.20,PP,0,1,,,20
Sims 2013.pdf,296313,Self-help,569,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,57.2,15.4,United States,0,0,1,201,26.10,PP,0,1,,,6.5
Sims 2013.pdf,296313,Counseling intervention,568,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,-,61.2,16.1,United States,0,0,1,209,26.10,PP,0,1,,,6.7
Skov-Ettrup 2014.pdf,319603,Untailored text messages,677,0,0,0,0,0,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,19.5,58.3,15.6,Danish,0,0,0,975,52.20,PP,0,1,,,14.5
Skov-Ettrup 2014.pdf,319603,Tailored text messages,676,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,19.4,60.3,15.4,Danish,0,0,0,1055,52.20,PP,0,1,,,17.9
Slama_1990_The effectiveness of two smoking cessation.pdf,252908,Control,79,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,Australia,0,0,0,106,52.20,NCS,0,0,12,months,8
Slama_1990_The effectiveness of two smoking cessation.pdf,252908,Simple advice,78,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,-,-,Australia,0,0,0,104,52.20,NCS,0,0,12,months,5
Slama_1990_The effectiveness of two smoking cessation.pdf,252908,Structured Behavioural Change,77,0,1,0,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,Australia,0,0,0,101,52.20,NCS,0,0,12,months,12
Smit 2016.pdf,423042,computer tailoring and counseling,2020,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,48.1,63.2,-,Dutch,0,0,0,93,52.20,C,1,0,,,15.1
Smit 2016.pdf,423042,computer tailoring without counseling,2021,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,47.8,58.3,-,Dutch,0,0,0,75,52.20,C,1,0,,,26.7
Smit 2016.pdf,423042,usual care,2022,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,48.1,57.1,-,Dutch,0,0,0,64,52.20,C,1,0,,,18.8
Smith 2001 primary paper.pdf,263260,MI / Supportive Group Counselling (MIS),377,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,-,4.35,PP,0,1,,,13
Smith 2001 primary paper.pdf,263260,CBT/ Skill Training Group Counselling,376,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,0,0,-,4.35,PP,0,1,,,10
Smith 2001 primary paper.pdf,263260,Brief intervention (BI),378,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,42,55,-,-,0,0,0,-,4.35,PP,0,1,,,18
Smith 2014.pdf,423123,Culturally Tailored Treatment (CTT),1944,0,1,0,0,0,1,1,0,0,0,1,1,1,1,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,40.1,60,14.8,-,0,0,0,50,26.10,PP,0,1,,,14
Smith 2014.pdf,423123,Standard Treatment (ST),1945,1,1,0,0,0,1,1,0,0,1,1,1,1,1,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,39.4,64.2,13.9,-,0,0,0,53,26.10,PP,0,1,,,22.6
Smits 2016.pdf,280787,Exercise (ST+EX),381,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,-,United States,0,0,0,7,130.50,PP,0,1,,,23.3
Smits 2016.pdf,280787,Wellness education control condition (ST+CTRL),382,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,-,-,United States,0,0,0,6,130.50,PP,0,1,,,10.2
Snaterse 2018.pdf,437567,Intervention,2611,0,1,0,1,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,1,58.7,22,-,Netherlands,0,0,0,172,52.20,NCS,0,0,,,50
Snaterse 2018.pdf,437567,Usual care,2612,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,1,58.7,22,-,Netherlands,0,0,0,166,52.20,NCS,0,0,,,46
Solomon 2000.pdf,296316,Patch + support,583,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32.9,-,6,-,0,1,1,106,26.10,PP,0,1,,,20
Solomon 2000.pdf,296316,Patch only,584,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33.2,-,6,-,0,1,1,108,26.10,PP,0,1,,,15
Solomon 2005.pdf,296317,Experimental,585,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,33.7,-,23.6,-,0,0,0,171,26.10,PP,0,1,,,28.7
Solomon 2005.pdf,296317,Control,586,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,34.8,-,23.6,-,0,0,0,159,26.10,PP,0,1,,,19.5
Sood 2009.pdf,296318,reactive telephone counseling,587,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,42.84,61.5,23.19,-,0,0,0,261,52.20,PP,0,1,,,14
Sood 2009.pdf,296318,self-help,588,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42.48,63.5,22.01,-,0,0,0,260,52.20,PP,0,1,,,15
Sorensen 2007.pdf,296319,Intervention,589,0,0,0,1,0,1,1,0,1,0,1,0,0,1,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,40.3,6,-,US and Canada,0,0,0,134,26.10,PP,0,1,,,19
Sorensen 2007.pdf,296319,Control,590,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40.8,5,-,US and Canada,0,0,0,113,26.10,PP,0,1,,,8
Stanczyk 2016.pdf,423043,control condition,2025,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.2,59.6,19,-,0,0,0,721,26.10,C,1,0,,,12.1
Stanczyk 2016.pdf,423043,text-based computer tailoring group,2024,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,45.4,60.9,18.7,-,0,0,0,708,26.10,C,1,0,,,14
Stanczyk 2016.pdf,423043,video-based computer tailoring,2023,0,0,0,0,0,1,1,1,1,0,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,45.5,62.2,19,-,0,0,0,670,26.10,C,1,0,,,14.6
Stanton 2015.pdf,423124,Brief advice (enhanced standard care [ESC]),1947,1,1,0,0,1,1,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,45,36,-,United States,1,0,0,148,52.20,PP,0,1,,,7
Stanton 2015.pdf,423124,Tailored intervention (Aurora),1946,0,1,0,0,0,1,0,0,0,0,1,1,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,45,36,-,United States,1,0,0,154,52.20,PP,0,1,,,6
Stein 2006a possible primary.pdf,263263,Maximum,383,0,1,0,1,0,1,0,0,0,0,0,1,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,39.9,48.2,26.3,-,0,1,1,191,26.10,PP,0,1,,,6.4
Stein 2006a possible primary.pdf,263263,Minimum,384,0,1,0,0,1,1,0,0,0,0,0,0,1,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,40.3,45.8,27.2,-,0,1,1,192,26.10,PP,0,1,,,5.8
Stewart_1982_The impact of routine advice on.pdf,252909,Questionnaire and Advice,81,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,Canada,0,0,0,345,52.20,C,1,0,12,months,3.1
Stewart_1982_The impact of routine advice on.pdf,252909,Questionnaire (Control),82,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,-,-,-,Canada,0,0,0,187,52.20,C,1,0,12,months,3.1
Stewart_1982_The impact of routine advice on.pdf,252909,"Questionnaire, Advice and Pamphlet",80,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,-,-,-,Canada,0,0,0,159,52.20,C,1,0,12,months,4.3
Stotts 2002.pdf,296320,Experimental group,591,0,0,0,1,0,1,1,0,1,0,1,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,28.6,-,-,United Kingdom,0,0,0,84,26.10,NCS,0,0,,,12.2
Stotts 2002.pdf,296320,Control,594,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,28.1,-,-,United Kingdom,0,0,0,82,26.10,NCS,0,0,,,17.1
Sutton 2007.pdf,296479,Control,854,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,37.7,66.9,20.6,United Kingdom,0,0,0,743,26.10,C,1,0,,,13.7
Sutton 2007.pdf,296479,Intervention,853,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,38.4,64.8,20.5,United Kingdom,0,0,0,765,26.10,C,1,0,,,14.5
Swan 2003a.pdf,296321,300mg buproprion +  Zyban Advantage Plan (ZAP),595,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,44.5,53.2,23.2,United States,0,0,0,378,52.20,PP,0,1,,,25.7
Swan 2003a.pdf,296321,300mg buproprion + Free & Clear (FC),596,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,44.6,56.4,23.1,United States,0,0,0,383,52.20,PP,0,1,,,33.2
Swan 2003a.pdf,296321,150mg buproprion + FC,598,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,46.1,59.7,23.8,United States,0,0,0,382,52.20,PP,0,1,,,31.4
Swan 2003a.pdf,296321,150mg bupriorion + ZAP,597,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,45,60.4,22.7,United States,0,0,0,381,52.20,PP,0,1,,,23.6
Swan 2010.pdf,296323,PTC,600,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,47,65.2,19.5,United States,0,1,1,402,26.10,PP,0,1,,,30.6
Swan 2010.pdf,296323,Web,601,0,0,0,0,0,0,0,1,0,1,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,47.1,66.8,19.8,United States,0,1,1,401,26.10,PP,0,1,,,27.4
Swan 2010.pdf,296323,proactive telephone-based counseling (PTC)Web,599,0,0,0,0,0,0,1,1,0,1,1,1,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,47.9,68.7,19.8,United States,0,1,1,399,26.10,PP,0,1,,,30.3
Taylor 1996.pdf,263269,Intervention,387,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,-,45,21.6,-,0,0,0,315,52.00,PP,0,1,,,31
Taylor 1996.pdf,263269,Usual care,388,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,45,21.4,-,0,0,0,313,52.00,PP,0,1,,,21
The Preloading Investigators 2018.pdf,423138,Preloading arm,2049,0,1,0,0,0,1,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,1,49.1,47.4,19.1,England,0,1,1,899,52.20,C,1,0,,,14
The Preloading Investigators 2018.pdf,423138,Control arm,2050,1,1,0,0,0,1,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,48.8,47.3,18.7,England,0,1,1,893,52.20,C,1,0,,,11.3
Thorley 2019.pdf,437472,Intervention,2354,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,1,1,0,1,1,1,0,1,1,0,0,1,1,1,1,0,0,1,0,0,0,0,1,53.96,35.64,-,UK,0,0,0,202,13.05,C,1,0,,,13.9
Thorley 2019.pdf,437472,Comparator,2355,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,1,1,0,1,1,1,0,1,1,0,0,1,1,1,1,0,0,0,0,0,0,0,1,55.58,42.57,-,UK,0,0,0,202,13.05,C,1,0,,,14.4
Tong 2018.pdf,437572,Moderate-intensity,2634,0,1,0,0,0,0,0,0,1,0,1,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,53.2,-,11.7,Mexico,0,0,0,94,52.20,PP,0,1,,,20.7
Tong 2018.pdf,437572,Brief-intensity,2635,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,53.4,-,12,Mexico,0,0,0,109,52.20,PP,0,1,,,20
Tonnesen 1996.pdf,296374,Control group,447,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,-,0,1,1,253,4.35,C,1,0,,,1.2
Tonnesen 1996.pdf,296374,Motivational group,446,0,1,0,0,0,0,0,0,0,0,0,1,1,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,1,-,-,-,-,0,1,1,254,4.35,C,1,0,,,3.1
Tonnesen 2006.pdf,296375,Placebo + low support,1039,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,1,0,1,62.5,-,20.2,-,0,1,1,88,52.20,C,1,0,,,5
Tonnesen 2006.pdf,296375,Placebo + high support,1038,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,1,0,1,61.2,-,19.9,-,0,1,1,97,52.20,C,1,0,,,6
Tonnesen 2006.pdf,296375,Nicotine + high support,448,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,1,0,1,61.3,-,18.3,-,0,1,1,90,52.20,C,1,0,,,14
Tonnesen 2006.pdf,296375,Nicotine + low support,449,0,1,0,0,0,0,1,0,0,0,1,1,0,1,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,1,0,1,59.2,-,20.1,-,0,1,1,95,52.20,C,1,0,,,14
Tseng 2017.pdf,436365,Standard Care (SC),2663,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,46.64,18.9,15.1,-,0,1,1,53,12.00,PP,0,1,,,5.7
Tseng 2017.pdf,436365,TM plus cell phone-delivered adherence-focused motivational and behavioral therapy (SC+TM+ABT),2661,0,1,0,0,0,1,1,1,0,0,1,1,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,1,0,0,0,0,47.76,17.6,15.3,-,0,1,1,51,12.00,PP,0,1,,,15.7
Tseng 2017.pdf,436365,SC + Text Message Support (SC+TM),2662,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,1,0,0,0,0,0,46,18.5,14.2,-,0,1,1,54,12.00,PP,0,1,,,3.7
Tulloch 2016.pdf,423141,NRT+ group,2054,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,1,1,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,48.57,46.5,24,United States,1,0,1,233,52.00,C,1,0,,,12.4
Tulloch 2016.pdf,423141,NRT group,2055,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,48.13,44.1,22.4,United States,1,0,1,230,52.00,C,1,0,,,10
Tulloch 2016.pdf,423141,VR group,2053,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,49.11,48.6,23.3,United States,1,0,1,236,52.00,C,1,0,,,15.3
Twardella 2007 primary paper.pdf,263270,Training and medication (TM),390,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,1,-,49,-,Germany,0,0,0,144,52.20,PP,0,1,,,12
Twardella 2007 primary paper.pdf,263270,"Training, medication and incentives (TM + TI)",389,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,1,1,0,0,1,-,55,-,Germany,0,0,0,221,52.20,PP,0,1,,,15
Twardella 2007 primary paper.pdf,263270,Usual care,392,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,1,-,50,-,Germany,0,0,0,76,52.20,PP,0,1,,,3
Twardella 2007 primary paper.pdf,263270,Training and incentives (TI),391,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,1,-,51,-,Germany,0,0,0,146,52.20,PP,0,1,,,3
Tzelepis 2011.pdf,296324,Control,603,1,0,0,0,0,0,0,0,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44.4,51.5,18.9,Australia,0,0,0,793,56.55,C,1,0,,,0.8
Tzelepis 2011.pdf,296324,Proactive telephone counseling,602,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,45.4,49.8,19.9,Australia,0,0,0,769,56.55,C,1,0,,,1.4
Unrod 2016.pdf,423093,Repeated mailings,2079,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,44,43.4,19.8,-,0,0,1,1142,104.40,PP,0,1,,,48
Unrod 2016.pdf,423093,Usual care,2080,1,0,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,44,48.3,19.2,-,0,0,1,1189,104.40,PP,0,1,,,45.4
Unrod 2016.pdf,423093,Massed mailings,2078,0,0,0,0,0,0,1,0,0,0,1,1,0,1,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,43.8,45.7,20.3,-,0,0,1,1127,104.40,PP,0,1,,,44.3
Unrod_2007_Randomized controlled trial of a computer_10.1007s11606-006-0069-0.pdf,252911,Computer-tailored intervention,85,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,1,43.5,58,13.3,-,0,0,0,237,26.10,PP,0,1,6,months,12
Unrod_2007_Randomized controlled trial of a computer_10.1007s11606-006-0069-0.pdf,252911,Control,86,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,42.8,64,14.4,-,0,0,0,228,26.10,PP,0,1,6,months,8
Vander Weg 2016.pdf,423126,Tailored tobacco Intervention,1950,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,1,1,1,0,0,0,1,0,0,0,0,-,9.7,22.3,-,1,0,0,31,26.10,PP,0,1,,,29
Vander Weg 2016.pdf,423126,Quitline Referral,1951,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,1,1,0,0,1,0,0,1,1,1,1,0,0,0,0,0,0,0,0,-,15.6,27.2,-,1,0,0,32,26.10,PP,0,1,,,28
Veldheer 2018.pdf,437574,Forever Free (FF),2674,0,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,48.8,59.3,15.5,-,0,0,1,115,26.10,PP,0,1,,,40.7
Veldheer 2018.pdf,437574,Control,2675,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,51.1,60.7,15.4,-,0,0,1,115,26.10,PP,0,1,,,44.6
Velicer 2006.pdf,296325,Telecommunications + expert system intervention + nicotine replacement therapy + stage-matched manuals (TEL + EXP + NRT + MAN),604,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,49.93,24.2,23.85,U.S.,0,0,0,-,130.50,C,1,0,,,15
Velicer 2006.pdf,296325,Expert system intervention + nicotine replacement therapy + stage-matched manuals (EXP + NRT + MAN),605,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,50.6,24.36,24.31,U.S.,0,0,0,-,130.50,C,1,0,,,13.6
Velicer 2006.pdf,296325,Stage-matched manuals (MAN),607,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,50.52,21.22,25.18,U.S.,0,0,0,-,130.50,C,1,0,,,12.5
Velicer 2006.pdf,296325,Nicotine replacement therapy + stage-matched manuals (NRT + MAN),606,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,50.89,22.41,24.55,U.S.,0,0,0,-,130.50,C,1,0,,,10
Vetter_1990_Smoking prevention among people aged 60.pdf,252912,Intervention,9,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,-,-,-,-,0,0,0,237,26.10,NCS,0,0,6,months,14
Vetter_1990_Smoking prevention among people aged 60.pdf,252912,Control,10,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,-,-,-,-,0,0,0,234,26.10,NCS,0,0,6,months,9
Vidrine 2015.pdf,423256,Usual care (UC),1975,1,1,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,45,30,-,United Kingdom,0,0,0,172,13.05,PP,0,1,,,4.7
Vidrine 2015.pdf,423256,Cell phone intervention (CPI),1974,0,1,0,0,0,0,1,0,0,0,1,1,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,45,30,-,United Kingdom,0,0,0,178,13.05,PP,0,1,,,15.7
Vidrine 2016.pdf,423127,Mindfulness-Based Addiction Treatment (MBAT),1952,0,1,0,0,0,1,0,0,0,0,1,1,0,0,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,-,54.9,19.9,United Kingdom,0,0,0,154,26.00,PP,0,1,,,13
Vidrine 2016.pdf,423127,Cognitive Behavioral Treatment (CBT),1953,0,1,0,0,0,1,1,0,0,0,1,1,0,1,0,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,-,54.9,19.9,United Kingdom,0,0,0,155,26.00,PP,0,1,,,15.5
Vidrine 2016.pdf,423127,Usual Care (UC),1954,1,1,0,0,0,1,0,0,0,0,1,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,-,54.9,19.9,United Kingdom,0,0,0,103,26.00,PP,0,1,,,19.1
Vidrine 2019.pdf,423482,NRT plus text messaging,1977,0,1,0,0,0,0,1,0,0,0,1,1,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,45.7,49.8,-,United Kingdom,0,0,0,377,26.10,PP,0,1,,,12
Vidrine 2019.pdf,423482,NRT plus text messaging plus proactive counseling,1976,0,1,0,0,0,0,1,0,0,0,1,1,1,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,46.1,52.7,-,United Kingdom,0,0,0,377,26.10,PP,0,1,,,25.5
Vidrine 2019.pdf,423482,NRT,1978,0,1,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,45.6,49.8,-,United Kingdom,0,0,0,377,26.10,PP,0,1,,,12
Vilaplana 2014.pdf,423255,Intervention (SMS group),1979,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,43.04,-,25.26,-,0,0,0,104,13.05,C,1,0,,,74
Vilaplana 2014.pdf,423255,Control (no SMS group),1980,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,44.7,-,27.98,-,0,0,0,125,13.05,C,1,0,,,45.6
Volpp 2009 primary paper.pdf,263272,Incentive group,393,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45.5,34.4,20.1,United States,0,0,1,436,39.15,C,1,0,,,14.7
Volpp 2009 primary paper.pdf,263272,Control group,394,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.4,35.1,19.7,United States,0,0,1,442,39.15,C,1,0,,,5
Wagner 2016.pdf,423128,Group B (group),1956,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,1,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,45,58.7,-,United States,0,1,1,400,39.15,NCS,0,0,,,8.6
Wagner 2016.pdf,423128,Group A (individual),1955,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,45,58.7,-,United States,0,1,1,400,39.15,NCS,0,0,,,8.9
Wang 2018.pdf,437575,Acupuncture group,2679,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,7,10,China,0,0,0,-,16.00,PP,0,1,,,43
Wang 2018.pdf,437575,NRT group,2681,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,5,10,China,0,0,0,-,16.00,PP,0,1,,,44
Wang 2018.pdf,437575,Auricular point group,2680,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,-,8,10,China,0,0,0,-,16.00,PP,0,1,,,30
Warner 2016.pdf,423129,Intervention,1957,0,1,0,0,0,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,46.7,48,14.6,United States,0,0,1,300,26.10,PP,0,1,,,11
Warner 2016.pdf,423129,Control,1958,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,46,49,14.2,United States,0,0,1,300,26.10,PP,0,1,,,7
Webb 2013.pdf,296485,Standard,858,1,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,42.81,59,19.75,-,0,0,0,208,26.10,PP,0,1,,,13.9
Webb 2013.pdf,296485,Placebo-tailored,857,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41.76,55,19.58,-,0,0,0,216,26.10,PP,0,1,,,19.9
Webb Hooper 2017.pdf,423130,Culturally specific CBT,1959,0,1,0,0,0,1,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,49.48,39,18.2,-,0,0,0,168,52.20,PP,0,1,,,23.2
Webb Hooper 2017.pdf,423130,Standard CBT,1960,1,1,0,0,0,1,1,0,0,0,1,0,0,1,1,1,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,49.52,48,17.88,-,0,0,0,174,52.20,PP,0,1,,,20
Westmaas 2018.pdf,437576,Basic email group (BEG),2651,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,40.2,83.7,17.3,USA,0,0,0,354,26.10,PP,0,1,,,25.8
Westmaas 2018.pdf,437576,Deluxe email group (DEG),2650,0,0,0,0,0,1,1,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,41,82.5,17.2,USA,0,0,0,376,26.10,PP,0,1,,,32.7
Westmaas 2018.pdf,437576,Single email group (SEG),2652,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,39.6,83.8,17.6,USA,0,0,0,340,26.10,PP,0,1,,,23.7
Wewers 2009.pdf,263274,Control,396,1,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,-,-,19.4,-,0,0,0,155,52.20,PP,0,1,12,months,7.1
Wewers 2009.pdf,263274,Intervention,395,0,1,0,0,0,1,1,0,0,0,1,1,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,-,-,17.2,-,0,0,0,147,52.20,PP,0,1,12,months,12.2
Wewers 2017.pdf,423131,CHW face to face (CHWF2F),1961,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,-,65.7,22.3,United States,0,0,0,354,52.20,PP,0,1,,,13.3
Wewers 2017.pdf,423131,CHW Quitline (CHWQL),1962,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,-,69.8,20.9,United States,0,0,0,353,52.20,PP,0,1,,,10.7
White 2019.pdf,437474,Intervention,2360,0,1,0,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,44.3,77.5,17.8,US,0,0,0,101,13.05,PP,0,1,,,7.9
White 2019.pdf,437474,Control,2361,1,1,0,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,43.3,77.5,20.9,US,0,0,0,99,13.05,PP,0,1,,,3
Whiteley 2012.pdf,263276,Wellness program,398,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.98,-,17.58,-,0,0,0,164,52.00,C,1,0,,,3.7
Whiteley 2012.pdf,263276,Exercise program,397,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44.07,-,17.38,-,0,0,0,166,52.00,C,1,0,,,6.6
Wiggers 2006a primary paper.pdf,263278,Minimal intervention strategy adapted for cardiology inpatients (C+MIS+NRT),399,0,1,0,0,0,1,0,0,0,0,1,1,1,0,1,1,0,0,1,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,59,37,21,Netherlands,0,0,0,193,52.20,PP,0,1,,,28
Wiggers 2006a primary paper.pdf,263278,Nicotine Replacement Therapy (NRT),400,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,58,38,21,Netherlands,0,0,0,191,52.20,PP,0,1,,,24
Willemsen 2006.pdf,296486,Control group,860,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-,45.9,-,multinational,0,0,0,514,26.10,C,1,0,,,5.1
Willemsen 2006.pdf,296486,Intervention group,859,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,46.6,-,multinational,0,0,0,500,26.10,C,1,0,,,5
Wilson 2008 primary paper.pdf,263281,Group Support (GS),402,0,1,0,1,1,1,1,0,0,0,1,0,1,1,1,1,0,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,60.4,59,20.1,Northern Ireland,0,0,0,29,52.20,C,1,0,,,0
Wilson 2008 primary paper.pdf,263281,Usual care,1032,1,1,0,0,1,1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,61.4,49,17.5,Northern Ireland,0,0,0,35,52.20,C,1,0,,,0
Wilson 2008 primary paper.pdf,263281,Individual Support (IS),401,0,1,0,1,1,1,1,0,0,0,1,0,1,1,1,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,61,48,20.8,Northern Ireland,0,0,0,27,52.20,C,1,0,,,0
Windle 2018.pdf,437577,Varenicline,2686,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,54.7,25.8,21.9,multinational,0,1,1,148,52.00,PP,0,1,,,39.9
Windle 2018.pdf,437577,Placebo,2687,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,55.3,23.8,21,multinational,0,1,1,151,52.00,PP,0,1,,,29.1
Winhusen-2014 primary paper.pdf,263285,Treatment as usual + smoking cessation treatment (TAU+SCT),403,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,36.9,45.7,16.7,-,0,0,0,267,26.10,PP,0,1,,,13.1
Winhusen-2014 primary paper.pdf,263285,Treatment as usual (TAU),404,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,50.2,16,-,0,0,0,271,26.10,PP,0,1,,,3.7
Winickoff 2014.pdf,263287,Intervention,405,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,30,78.6,11.7,United States,1,0,0,999,52.20,PP,0,1,,,4.3
Winickoff 2014.pdf,263287,Control,406,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30.6,77.9,10.3,United States,1,0,0,981,52.20,PP,0,1,,,4.1
Wittekind_B_2019.pdf,437476,AAMT Group,2601,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41.67,-,17.09,-,1,0,1,54,4.00,PP,0,1,4,weeks,61
Wittekind_B_2019.pdf,437476,Sham group,2602,0,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42.78,-,17.43,-,1,0,1,51,4.00,PP,0,1,4,weeks,61
Yalcin 2014.pdf,263289,Study group,407,0,1,0,0,0,1,1,0,0,0,1,0,0,0,1,1,1,1,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35.25,-,-,Turkey,0,0,0,175,25.71,NCS,0,0,180,days,44
Yalcin 2014.pdf,263289,Control group,408,1,1,0,0,0,1,1,0,0,0,1,0,0,0,1,1,1,1,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37.19,-,-,Turkey,0,0,0,175,25.71,NCS,0,0,180,days,27.4
Yingst 0218.pdf,437578,Control,2795,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,44.5,71,18,-,0,1,1,76,12.00,PP,0,1,,,30.3
Yingst 0218.pdf,437578,Intervention,2794,0,1,0,0,0,1,0,1,0,0,1,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,46.6,60.8,17.4,-,0,1,1,74,12.00,PP,0,1,,,31.1
Young BMC Family Pract 2008.pdf,296326,Telephone,608,0,0,0,0,0,1,1,1,0,0,1,1,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,1,0,0,39,49,-,Australia,0,0,0,169,52.20,PP,0,1,,,8
Young BMC Family Pract 2008.pdf,296326,Usual care,609,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,59,-,Australia,0,0,0,149,52.20,PP,0,1,,,6
Yu 2017.pdf,436366,Intervention Group A (I-A),2665,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.8,-,-,China,0,0,0,102,52.20,NCS,0,0,,,16.7
Yu 2017.pdf,436366,Control Group,2666,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.6,-,-,China,0,0,0,93,52.20,NCS,0,0,,,9.7
Yu 2017.pdf,436366,Intervention Group B (I-B),2664,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31.9,-,-,China,0,0,0,97,52.20,NCS,0,0,,,22.7
Zarghami 2018.pdf,437579,Combined GSC-NRT,2352,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,54,-,20,Iran,0,0,0,19,29.00,NCS,0,0,,,47.4
Zarghami 2018.pdf,437579,Guided Self-Change,2357,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,-,24,Iran,0,0,0,19,29.00,NCS,0,0,,,47.4
Zarghami 2018.pdf,437579,Nicotine Replacement Therapy (NRT),2353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,56,-,26,Iran,0,0,0,19,29.00,NCS,0,0,,,21.1
Zheng-2007.pdf,263291,Control group,410,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53.2,8.5,14.9,China,0,0,0,107,26.10,C,1,0,,,3
Zheng-2007.pdf,263291,Intervention group,409,0,1,0,0,0,0,1,0,0,1,0,1,0,1,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,56.4,4.7,15.4,China,0,0,0,118,26.10,C,1,0,,,28.4
Zhu 1996.pdf,296327,Single counseling,611,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.3,57,20.2,Guatemala,0,0,0,1143,52.20,C,1,0,,,7.5
Zhu 1996.pdf,296327,Multiple counseling,610,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.3,57,20.2,Guatemala,0,0,0,1046,52.20,C,1,0,,,9.9
Zhu 1996.pdf,296327,Self help,612,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36.3,57,20.2,Guatemala,0,0,0,841,52.20,C,1,0,,,5.4
Zhu 2012.pdf,296329,Counseling + self-help,615,0,0,0,0,0,1,1,0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,10,15.6,-,0,0,0,1124,30.45,C,1,0,,,16.4
Zhu 2012.pdf,296329,Self-help only,616,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,10,15.6,-,0,0,0,1153,30.45,C,1,0,,,8
Zhu NEJM 2002.pdf,296328,Treatment,613,0,0,0,0,0,1,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38.6,55.3,21,United States,0,0,0,1973,56.55,C,1,0,,,9.1
Zhu NEJM 2002.pdf,296328,Control,614,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37.9,57.6,20.1,United States,0,0,0,1309,56.55,C,1,0,,,6.9
de Vries_2006_The effects of smoking cessation counseling_10.1016j.pec.2005.10.002.pdf,263041,Experimental,106,0,0,0,0,0,1,1,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,28.6,-,9.1,Netherlands,0,0,0,141,-,C,1,0,na,,12
de Vries_2006_The effects of smoking cessation counseling_10.1016j.pec.2005.10.002.pdf,263041,Control,107,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28.4,-,7.7,Netherlands,0,0,0,177,-,C,1,0,na,,3
di Dios 2019.pdf,437441,Health Education (HE),2213,0,1,0,0,0,1,0,0,0,0,1,1,0,1,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,45.4,40,13.2,US,1,0,0,9,26.10,PP,0,1,,,44.4
di Dios 2019.pdf,437441,Culturally-Tailored Smoking Cessation (CTSC),2212,0,1,0,0,0,1,1,0,0,0,1,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,46,40,15.7,US,1,0,0,8,26.10,PP,0,1,,,25
di Dios 2019.pdf,437441,Culturally-Tailored Smoking Cessation plus Adherence Enhancement (CT+AE),2211,0,1,0,0,0,1,1,0,0,1,1,1,0,0,0,1,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,40.7,40,11.5,US,1,0,0,8,26.10,PP,0,1,,,37.5
tappin 2015.pdf,423245,Intervention group,2134,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,28.27,-,-,multinational,0,0,0,306,52.20,C,1,0,12,months,22.5
tappin 2015.pdf,423245,Control group,2135,1,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27.66,-,-,multinational,0,0,0,303,52.20,C,1,0,12,months,8.6
van Rossem 2017.pdf,423125,Individual counselling by a practice nurse (PN),1948,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,47.3,47,19.3,Netherlands,0,1,1,149,52.00,C,1,0,,,25.5
van Rossem 2017.pdf,423125,Brief advice by a general practitioner (GP),1949,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,1,0,0,0,48.7,58.9,18.7,Netherlands,0,1,1,146,52.00,C,1,0,,,28.8
van den Brand 2018.pdf,423078,Intervention,1939,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43.9,32,-,multinational,0,0,0,319,52.20,C,1,0,,,41
van den Brand 2018.pdf,423078,Control,1940,1,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.6,42,-,multinational,0,0,0,284,52.20,C,1,0,,,26
van der Aalst 2012.pdf,296482,Standard brochure,856,0,0,0,0,0,0,1,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,1,1,642,8.70,C,1,0,,,15.6
van der Aalst 2012.pdf,296482,Computer Tailored Smoking Cessation Intervention (CTSCI),855,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,-,-,-,-,0,1,1,642,8.70,C,1,0,,,12.5
Socio Demographics,263266,Intervention,385,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,1,0,1,1,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,38.1,48,22.2,Australia,0,0,0,104,26.10,C,1,0,,,1.9
Socio Demographics,263266,Control,386,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37.2,47,23.7,Australia,0,0,0,101,26.10,C,1,0,,,0
